GigPeak, Inc. - FORM 10-Q - November 17, 2010

GigPeak, Inc. - FORM 10-Q - November 17, 2010

Attached files

Attached files

GigPeak, Inc. Reports

file	filename
EX-31.1 - CHIEF EXECUTIVE OFFICER CERTIFICATION PURSUANT TO SECTION 302 - GigPeak, Inc.	dex311.htm
EX-32.1 - CHIEF EXECUTIVE OFFICER CERTIFICATION PURSUANT TO SECTION 906 - GigPeak, Inc.	dex321.htm
EX-32.2 - CHIEF FINANCIAL OFFICER CERTIFICATION PURSUANT TO SECTION 906 - GigPeak, Inc.	dex322.htm
EX-31.2 - CHIEF FINANCIAL OFFICER CERTIFICATION PURSUANT TO SECTION 302 - GigPeak, Inc.	dex312.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended October 3, 2010

¨	TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 333-153362

GIGOPTIX, INC.

(Exact name of registrant as specified in its charter)

Delaware

26-2439072

(State or Other Jurisdiction of

Incorporation or Organization)

(I.R.S. Employer

Identification No.)

2300 Geng Road, Suite 250,

Palo Alto, CA 94303

Registrant’s telephone number: (650-424-1937)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ¨ No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

The number of shares of Common Stock outstanding as of November 11, 2010 the most recent practicable date prior to the filing of this Quarterly Report on Form 10-Q, was 12,195,909 shares.


		PAGE NO
PART I FINANCIAL INFORMATION

ITEM 1	Financial Statements (unaudited)

	Condensed Consolidated Balance Sheets as of October 3, 2010 and December 31, 2009		1

	Condensed Consolidated Statements of Operations for the three and nine months ended October 3, 2010 and October 4, 2009		2

	Condensed Consolidated Statements of Cash Flows for the nine months ended October 3, 2010 and October 4, 2009		3

	Notes to Condensed Consolidated Financial Statements		4

ITEM 2	Management’s Discussion and Analysis of Financial Condition and Results of Operations		17

ITEM 4T	Controls and Procedures		24

PART II OTHER INFORMATION

ITEM 1	Legal Proceedings		25

ITEM 1A	Risk Factors		25

ITEM 6	Exhibits		41

PART I

FINANCIAL INFORMATION

GIGOPTIX, INC.

CONSOLIDATED BALANCE SHEETS

(In thousands, except share and per share amounts)

(Unaudited)


	October 3, 2010			December 31, 2009
ASSETS
Current assets:
Cash and cash equivalents	$	4,852		$	3,583
Accounts receivable, net		4,235			3,750
Inventories		1,846			1,457
Prepaid and other current assets		572			816

Total current assets		11,505			9,606
Property and equipment, net		4,042			4,334
Intangible assets, net		4,016			4,716
Goodwill		7,407			7,307
Restricted cash		404			601
Other assets		592			758

Total assets	$	27,966		$	27,322

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	3,117		$	4,376
Accrued and other current liabilities		4,592			5,403
Line of credit		3,271			1,324

Total current liabilities		10,980			11,103
Pension liabilities		199			186
Other long term liabilities		1,486			2,035

Total liabilities		12,665			13,324
Commitments and contingencies (Note 10)
Stockholders’ Equity
Preferred stock, $0.001 par value; 1,000,000 shares authorized; no shares issued and outstanding as of October 3, 2010 and December 31, 2009		—			—
Common stock, $0.001 par value; 50,000,000 shares authorized; 12,195,031 and 9,289,682 shares issued and outstanding as of October 3, 2010 and December 31, 2009, respectively		12			9
Additional paid-in capital		88,076			82,814
Accumulated deficit		(72,998	)		(68,993	)
Accumulated other comprehensive income		211			168

Total stockholders’ equity		15,301			13,998

Total liabilities and stockholders’ equity	$	27,966		$	27,322

See accompanying Notes to Consolidated Financial Statements

GIGOPTIX, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share amounts)

(Unaudited)


	Three months ended						Nine months ended
	October 3, 2010			October 4, 2009			October 3, 2010			October 4, 2009
Revenue
Product	$	5,866		$	2,142		$	16,525		$	7,582
Government contract		1,357			1,005			2,251			4,108

Total revenue		7,223			3,147			18,776			11,690
Cost of revenue
Product		3,106			964			8,329			3,100
Government contract		305			367			557			1,765

Total cost of revenue		3,411			1,331			8,886			4,865

Gross profit		3,812			1,816			9,890			6,825

Research and development expense		1,852			1,255			6,056			3,919
Selling, general and administrative expense		2,247			1,744			6,921			6,170
Restructuring expense		—			—			428			—

Total operating expenses		4,099			2,999			13,405			10,089

Loss from operations		(287	)		(1,183	)		(3,515	)		(3,264	)
Interest expense, net		(105	)		—			(335	)		(2	)
Other income (expense), net		(16	)		8			(132	)		338

Net loss before income taxes		(408	)		(1,175	)		(3,982	)		(2,928	)
(Provision for)/benefit from income taxes		2			(22	)		(22	)		107

Net loss		(406	)	$	(1,197	)		(4,004	)	$	(2,821	)

Net loss per share - basic and diluted	$	(0.03	)	$	(0.23	)	$	(0.39	)	$	(0.54	)

Shares used in computing basic and diluted net loss per shares		11,972			5,229			10,204			5,193

See accompanying Notes to Consolidated Financial Statements

GIGOPTIX, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)


	Nine months ended
	October 3, 2010			October 4, 2009
Cash flows from operating activities:
Net loss	$	(4,004	)	$	(2,821	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		2,021			685
Stock-based compensation expense		1,189			577
Write down of fixed assets		121			—
Amortizaton of discount on loan		152			—
Deferred taxes		—			(83	)
Amortization of acquisition-related payment		450			525
(Gain)/Loss on sale of assets		3			(300	)
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable, net		(481	)		(516	)
Inventories		(523	)		24
Prepaid and other current assets		(200	)		(2	)
Other assets		69			(118	)
Accounts payable		(1,259	)		34
Accrued and other current liabilities		(1,218	)		(1,163	)

Net cash used in operating activities		(3,680	)		(3,158	)

Cash flows from investing activities:
Purchases of property and equipment		(971	)		(427	)
Change in restricted cash		200
Proceeds from sale of assets		—			300

Net cash used in investing activities		(771	)		(127	)

Cash flows from financing activities:
Proceeds from issuance of common stock and common stock warrants		4,076			17
Proceeds from line of credit		12,977			792
Proceeds from short-term loan		900			—
Repayment of line of credit		(11,502	)		(1,592	)
Repayment of short-term loan		(579	)		—
Repayment of capital lease obligations		(157	)		—

Net cash provided by (used in) financing activities		5,715			(783	)

Effect of exchange rates on cash and cash equivalents		5			11
Net increase (decrease) in cash and cash equivalents		1,269			(4,057	)
Cash and cash equivalents at beginning of the period		3,583			6,871

Cash and cash equivalents at end of period	$	4,852		$	2,814

Supplemental disclosure of cash flow information:
Interest paid	$	213		$	29

See accompanying Notes to Consolidated Financial Statements

GIGOPTIX, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1—ORGANIZATION AND BASIS OF PRESENTATION

Organization

GigOptix, Inc. (GigOptix or the Company), the successor to GigOptix LLC, was formed as a Delaware corporation in March 2008 in order to facilitate a combination between GigOptix LLC and Lumera Corporation (Lumera). Before the combination, GigOptix LLC acquired the assets of iTerra Communications LLC in July 2007 (iTerra) and Helix Semiconductors AG (Helix) in January 2008. On November 9, 2009, GigOptix acquired ChipX, Incorporated (ChipX). As a result of the acquisitions, Helix, Lumera and ChipX all became wholly owned subsidiaries of GigOptix.

Going Concern

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and the liquidation of liabilities in the normal course of business. The Company has incurred significant losses since inception, attributable to its efforts to design and commercialize its products. For the nine months ended October 3, 2010 and the year ended December 31, 2009, the Company incurred net losses of $4.0 million and $10.0 million, respectively, and cash outflows from operations of $3.7 million and $4.1 million, respectively. As of October 3, 2010 and December 31, 2009, the Company had an accumulated deficit of $73.0 million and $69.0 million, respectively. The Company has managed its liquidity during this time through a series of cost reduction initiatives, sales of common stock and working capital management.

At December 31, 2009 the Company determined that due to its significant operating losses and negative cash flows through that date, among other factors, there was substantial doubt about its ability to continue as a going concern. At that time, the Company determined that it would need to raise additional capital and begin to generate positive and what the Company believes to be sustainable, Adjusted EBITDA (a measure of cash flow from operations, absent changes in working capital and capital equipment purchases) in order to continue as a going concern.

In July 2010 the Company closed a public offering in which it issued 2,760,000 shares of common stock at a price per share of $1.75, resulting in net proceeds to the Company of $3,900,000. In addition, for the three and nine months ended October 3, 2010 the Company had an Adjusted EBITDA of $868,000 and $725,000, respectively and currently anticipates that it will have positive Adjusted EBITDA for the rest of fiscal 2010. Given these two factors, as of October 3, 2010 management believes the Company can continue as a going concern through approximately the end of the quarter ended October 2, 2011.

Basis of Presentation

The Company’s fiscal year ends on December 31. For quarterly reporting, the Company employs a four-week, four-week, five week reporting period. The current three month period ended on Sunday, October 3, 2010. The third quarter of fiscal 2009 ended on Sunday, October 4, 2009. The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated.

The accompanying unaudited condensed consolidated financial statements as of October 3, 2010 and for the three and nine months ended October 3, 2010 and October 4, 2009, respectively, have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) for interim financial information and with the instructions to Article 10 of Securities and Exchange Commission (SEC) Regulation S-X, and include the accounts of the Company and all of its subsidiaries. Accordingly, they do not include all of the information and footnotes required by such accounting principles for annual financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation of the Company’s consolidated financial position and operations have been included. The condensed consolidated results of operations for the three and nine months ended October 3, 2010 are not necessarily indicative of results that may be expected for any other interim period or for the full fiscal year ending December 31, 2010.

GIGOPTIX, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Use of Estimates

The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates, judgments and assumptions that affect the reported amount of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reported periods. These judgments can be subjective and complex, and consequently, actual results could differ materially from those estimates and assumptions. Descriptions of these estimates and assumptions are included in the 2009 Form 10-K and the company encourages you to read its 2009 Form 10-K for more information about such estimates and assumptions.

NOTE 2—RECENT ACCOUNTING PRONOUNCEMENTS

In April 2010, the FASB issued Accounting Standards Update (ASU) 2010-17 which provides guidance on the recognition of revenue under the milestone method, which allows a vendor to adopt an accounting policy to recognize all of the arrangement consideration that is contingent on the achievement of a substantive milestone (milestone consideration) in the period the milestone is achieved. The pronouncement is effective on a prospective basis for milestones achieved in fiscal years and interim periods within those years, beginning on or after June 15, 2010. The Company does not expect the adoption of ASU 2010-17 to have a significant impact on its consolidated financial statements.

NOTE 3—BALANCE SHEET COMPONENTS (update)

Accounts receivable, net, consisted of the following (in thousands):


	October 3, 2010			December 31, 2009
Billed accounts receivable	$	4,128		$	3,591
Unbilled accounts receivable		327			321
Allowance for doubtful accounts		(220	)		(162	)

	$	4,235		$	3,750

Inventories consisted of the following (in thousands):


	October 3, 2010		December 31, 2009
Raw materials	$	977	$	506
Work in process		255		238
Finished goods		614		713

	$	1,846	$	1,457

Prepaid and other current assets consisted of the following (in thousands):


	October 3, 2010		December 31, 2009
Escrow payment related to continued employment	$	150	$	600
Other prepaid expenses and current assets		422		216

	$	572	$	816

GIGOPTIX, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Property and equipment, net consisted of the following (in thousands, except depreciable life):


	Depreciable Life		October 3, 2010			December 31, 2009
	(In years)
Network and laboratory equipment		3 - 5	$	5,782		$	4,878
Computer software and equipment		3		2,557			2,551
Furniture and fixtures		3 - 10		152			152
Licensed property		2		468			468
Office equipment		3 - 5		55			50
Leasehold improvements		1 - 5		120			81
Construction-in-progress		—		264			229

				9,398			8,409
Accumulated depreciation and amortization				(5,356	)		(4,075	)

Property and equipment, net			$	4,042		$	4,334

Depreciation and amortization expense related to property and equipment was $412,000 and $98,000 for the three months ended October 3, 2010 and October 4, 2009, respectively. Depreciation and amortization expense related to property and equipment was $1.2 million and $312,000 for the nine months ended October 3, 2010 and October 4, 2009, respectively. A write down of fixed assets of $121,000 was recorded as part of a restructuring of the Company’s Israel Design Center during the nine months ended October 3, 2010.

Other assets consisted of the following (in thousands):


	October 3, 2010		December 31, 2009
Severance fund	$	399	$	666
Other		193		92

	$	592	$	758

Accrued and other current liabilities consisted of the following (in thousands):


	October 3, 2010		December 31, 2009
Additional billings repayable to US Government	$	1,154	$	1,275
Accrued legal and professional services		218		1,079
Accrued compensation and related taxes		1,141		1,007
Customer deposit		522		467
Deferred revenue		334		88
Accrued restructuring		173		339
Other		1,050		1,148

	$	4,592	$	5,403

GIGOPTIX, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Other long – term liabilities consisted of the following (in thousands):


	October 3, 2010		December 31, 2009
Capital lease obligation	$	1,062	$	1,227
Severance liability in Israel		424		722
Restructuring liability		—		86

	$	1,486	$	2,035

NOTE 4—BUSINESS COMBINATIONS

Acquisition of ChipX, Incorporated

On November 9, 2009, the Company completed an acquisition of ChipX, a privately-held fabless supplier of analog and mixed signal custom Application Specific Integrated Circuits (ASICs). The acquisition of ChipX provides the Company with a portfolio of intellectual property and complementary skills that will enable GigOptix to develop new products to expand its offering to the optically connected market. Under the terms of the ChipX Transaction, ChipX stockholders received, in aggregate, 3,540,946 shares of GigOptix common stock. The net assets, including identifiable tangible and intangible assets and liabilities, including interest bearing debt of ChipX assumed by the Company as of the effective time of the ChipX transaction, were recorded at their respective fair values.

The purchase consideration for the merger was approximately $12.5 million, which consisted of the fair value of 3.5 million shares of GigOptix common stock issued to ChipX’s stockholders, was determined using a per share price of $3.50, which reflects the closing price of the Company’s common stock on November 9, 2009.

NOTE 5—INTANGIBLE ASSETS AND GOODWILL

Intangible assets consist of the following (in thousands):


	October 3, 2010							December 31, 2009
	Gross		Accumulated Amortization			Net		Gross		Accumulated Amortization			Net
Existing technology	$	2,328	$	(1,318	)	$	1,010	$	2,328	$	(1,191	)	$	1,137
Order backlog		459		(447	)		12		459		(211	)		248
Customer relationships		2,558		(407	)		2,151		2,558		(173	)		2,385
Trade name		577		(53	)		524		577		(8	)		569
Patents		457		(138	)		319		457		(80	)		377

Total	$	6,379	$	(2,363	)	$	4,016	$	6,379	$	(1,663	)	$	4,716

Amortization expense of intangible assets included in cost of revenue and selling, general and administrative expenses was approximately $231,000 and $700,000, respectively during the three and nine months ended October 3, 2010. Amortization expense of intangible assets included in cost of revenue and selling, general and administrative expenses was approximately $131,000 and $375,000, respectively during the three and nine months ended October 4, 2009.

GIGOPTIX, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Estimated future amortization expense related to intangible assets as of October 3, 2010 is as follows (in thousands):


Years ending December 31,	Amount
2010 (remaining period)	$	154
2011		607
2012		607
2013		605
2014		532
Thereafter		1,511

Total	$	4,016

In addition to its annual review, the Company also performs a review of the carrying value of its intangible assets if the Company believes that indicators of impairment exist. In its review, the Company compares the gross, undiscounted cash flows expected to be generated by the underlying assets against the carrying value of those assets. To the extent such cash flows do not exceed the carrying value of the underlying asset the Company will record an impairment charge. The Company did not record an impairment charge during the three or nine months ended October 3, 2010. In the three months ended December 31, 2009, the Company determined that due to a sharp decline in revenue in the fourth quarter, an impairment analysis of the intangibles related to existing technology and customer relationships acquired in the acquisition of Helix was warranted. The Company estimated the fair value of the intangible assets using undiscounted forecasted cash flows; this represents a Level 3 fair value measurement. The analysis indicated that the carrying value of the intangible assets should be reduced to zero and, accordingly, the Company recorded an impairment charge of $436,000. The Company performs an impairment analysis of goodwill on an annual basis. The Company did not record an impairment of goodwill for the year ended December 31, 2009 and will perform an analysis as of December 31, 2010.

In connection with our acquisition of ChipX on November 9, 2009, the Company recorded goodwill of $7.4 million. The acquisition of ChipX provides the company access to new customers and markets, broadens our portfolio of products, technology and customers, and also will enable the Company to integrate and leverage its technology into new products and solutions for the optical interconnect market. These factors primarily contributed to a purchase price that resulted in goodwill, which is not deductible for tax purposes.

NOTE 6—LINE OF CREDIT AND SHORT-TERM LOAN

On April 23, 2010 the Company entered into a loan and security agreement with Silicon Valley Bank (SVB). Pursuant to the Loan Agreement, the Company is entitled to borrow from SVB up to $3 million based on net eligible accounts receivable after an 80% advance rate and subject to limits based on the Company’s eligible accounts as determined by SVB (the Revolving Loan). Interest on extensions of credit under the Revolving Loan is equal to the prime rate of SVB, which is currently 4.0% per annum, plus 1.5% per annum (the Applicable Rate). In addition, a monthly collateral handling fee of 0.30% per each gross financed account receivable shall apply (Collateral Handling Fee). If the Company achieves certain quarterly financial performance targets as stated in the loan agreement, the Applicable Rate and the Collateral Handling Fee shall be reduced to the prime rate of SVB plus 1.0% per annum and 0.20%, respectively. The Revolving Loan will be used by the Company to replace its revolving accounts receivable credit line with Bridge Bank. With the initial funding by SVB of the Revolving Loan, the Company has terminated its loan and security agreement with Bridge Bank, which is discussed below, as having been fully performed by the Company. The Loan Agreement also contains events of default customary for credit facilities of this type, including, among other things, nonpayment of principal or interest when due. The Loan Agreement will expire on April 23, 2012.

Pursuant to the Loan Agreement, SVB is making available a term loan (the Term Loan) in an amount up to $400,000, subject to the satisfaction of terms and conditions of the Loan Agreement, which can be drawn down one time for the purpose of refinancing the Company’s outstanding obligations to Agility Capital. The Term Loan is repayable in eighteen equal monthly installments and interest is fixed at a rate per annum of 9.0%. The Company used the proceeds of the Term Loan to pay off its loan and terminate its loan agreement with Agility Capital.

GIGOPTIX, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

The Loan Agreement is secured by all assets of the Company, including all accounts, equipment, inventory, receivables, and intangibles. The Loan contains certain restrictive covenants that will impose significant operating and financial restrictions on the Company’s operations, including, but not limited to:

•

Merge or consolidate, or permit any of its subsidiaries to merge or consolidate, with or into any other business organization, or acquire, or permit any of its subsidiaries to acquire, all or substantially all of the capital stock or property of another person;

•

Create, incur, assume or be liable for any indebtedness, other than certain indebtedness permitted under the Loan Agreement; or

•

Pay any dividends or make any distribution or payment on, or redeem, retire, or repurchase, any capital stock.

In connection with the Loan Agreement, the Company granted SVB (i) a warrant to purchase 125,000 shares of the Company’s common stock at an exercise price equal to $4.00 per share, or the Warrant, and (ii) a warrant to purchase a second tranche of up to 100,000 shares of the Company’s common stock which shall vest 15,000 shares per month incrementally beginning September 1, 2010 (although the last monthly incremental vesting amount shall be 10,000 shares) at an exercise price equal to the closing market price on each date of vesting; or the Second Tranche Warrant. In the event that either an Equity Investment has closed or the Company has been EBITDA positive for the preceding three months, then vesting shall cease, and all unvested shares under the Second Tranche Warrant shall lapse. In July 2010, the Company satisfied the requirements of an Equity Investment and the Second Tranche Warrant expired. The Warrant includes anti-dilution provisions and “piggy-back” registration rights permitting registration in a future public offering by the Company. The Warrant may either be (i) converted, on a cashless, net settlement basis, based on the fair market value as determined pursuant to the terms of the Warrant, or (ii) exercised by delivering a duly executed notice of exercise. The Warrant has a term of seven years; the fair value of the Warrant has been determined using a Black-Scholes option pricing model. The Warrant has a fair value of $357,000 and is being amortized over a two year period. The Company recorded stock based expense of $45,000 and $80,000 during the three and nine months ended October 3, 2010, respectively.

In November 2009, we entered into a loan and security agreement (Credit Agreement) with Bridge Bank under which we could borrow up to $4.0 million, based on net eligible accounts receivable. Borrowings under the line of credit bore interest at the bank’s prime rate plus 2.50% (6.50% as of December 31, 2009), provided that in no event would the prime rate be less than 4.0%. Borrowings under the line were collateralized by a security interest in all of our assets. At December 31, 2009, the amount outstanding under the line of credit was $1.3 million, which is classified within current liabilities.

In connection with the Credit Agreement, the Company issued warrants to purchase 59,773 shares of the Company’s common stock to Bridge Bank at an exercise price of $3.35 per share. The warrants have a seven year life from the date of issuance and have a fair value of approximately $152,000 which was recorded in the quarter ended December 31, 2009 as an increase in additional paid-in-capital and a discount from the face value of the debt.

On January 29, 2010, the Company, entered into a loan agreement for a secured line of credit facility (Secured Credit Facility) with Agility Capital, LLC (Agility Capital) to pay for transaction expenses incurred by the Company in its acquisition of ChipX. The Secured Credit Facility provides that the Company may borrow one advance of up to $500,000 and has a maturity date of December 1, 2010. Borrowings will bear interest at 14.0% per annum. Beginning March 1, 2010, and on the first day of each month thereafter, $50,000 plus accrued but unpaid interest is to be paid to Agility Capital, and all amounts outstanding on December 1, 2010 are due and payable at that time. In the event of a default, the interest rate will be increased to 5.0% above the rate that would otherwise apply, and in addition, Agility will receive a fee of $5,000, with an additional fee of $5,000 on each thirtieth day thereafter for so long as the event of default continues.

Under the terms of the Secured Credit Facility, the Company paid Agility Capital a $20,000 fee. Additionally, the Company issued a warrant for the purchase of 71,429 shares of the Company’s common stock. The warrant may either be (i) converted, on a cashless, net settlement basis, based on the fair market value as determined pursuant to the terms of the warrant, or (ii) exercised at a price per share equal to the lower of $2.10 or the price paid in the next offering or issuance of the Company’s common stock, if such offering occurs by April 29, 2010. The

GIGOPTIX, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

warrant has a term of seven years and a fair value of $106,000 which was expensed immediately to sales, general and administrative expense for the three months ended April 4, 2010. In the event of a default under the Secured Credit Facility, Agility Capital can acquire an additional 25,000 shares of the Company’s common stock at an exercise price equal to the average closing price of the Company’s common stock for the fifteen days before the date of the occurrence of the event of default, and an additional 35,000 shares on each thirtieth day thereafter for so long as the event of default continues, provided the aggregate additional shares which Agility Capital may acquire does not exceed 100,000 shares.

On April 28, 2010 the Company paid Bridge Bank approximately $1.6 million to fully repay its liabilities covering principal accrued interest, and various fees related to its line of credit. On April 28, 2010 the Company paid Agility Capital $404,000 to fully repay its liabilities covering principal and accrued interest related to its short-term loan.

NOTE 7—STOCKHOLDERS’ EQUITY

Common and Preferred Stock

In December 2008, the Company’s stockholders approved an amendment to the Certificate of Incorporation to authorize 50,000,000 shares of common stock of par value $0.001. In addition, the Company is authorized to issue 1,000,000 shares of undesignated preferred stock of $0.001 par value, for which the Board of Directors is authorized to fix the designation, powers, preferences and rights. As of October 3, 2010 and December 31, 2009, there were no shares of preferred stock issued or outstanding.

Equity Incentive Plan

On December 9, 2008, at the effective time of the merger with Lumera, all shares and per share amounts for GigOptix LLC awards were converted at the merger conversion ratio of 0.1375.

As of October 3, 2010 there were 4,982,586 options and 4,125 warrants outstanding under all stock option plans. As of December 31, 2009 there were 3,085,160 options and 4,125 warrants outstanding under all stock option plans. As of October 4, 2009 there were 2,866,393 options, 50,092 unvested shares of restricted stock units and 83,925 warrants outstanding under all stock option plans. All 54,629 shares of unvested restricted stock had vested by December 31, 2009.

2007 Equity Incentive Plan

In August 2007, GigOptix LLC adopted the GigOptix LLC Equity Incentive Plan, or the 2007 Plan. The 2007 Plan provides for grants of options to purchase membership units and awards of restricted membership units to employees, officers and non-employee directors, and upon the completion of the merger with Lumera were converted into grants of up to 632,500 shares of stock. Vesting periods are determined by the Company’s Board of Directors and generally provide for stock options to vest over a four-year period and expire ten years from date of grant. Vesting for certain stock unit grants are contingent upon both service and performance criteria. The 2007 Plan was terminated upon the completion of merger with Lumera on December 9, 2008 and the remaining 864 stock options not granted under the 2007 Plan were cancelled. No shares of the Company’s common stock remain available for issuance of new grants under the 2007 Plan other than for satisfying exercises of stock options granted under this plan prior to its termination. As of October 3, 2010, no shares of common stock have been reserved for issuance under the 2007 Plan and options to purchase a total of 453,432 shares of common stock and 4,125 warrants to purchase common stock were outstanding.

2008 Equity Incentive Plan

In December 2008, the Company adopted the 2008 Equity Incentive Plan, or the 2008 Plan, for directors, employees, consultants and advisors to the Company or its affiliates. Under the 2008 Plan, 2,500,000 shares of common stock were reserved for issuance upon the completion of the merger with Lumera on December 9, 2008. On January 1 of each year, starting in 2009, the aggregate number of shares reserved for issuance under the 2008 Plan increase automatically by the lesser of (i) 5% of the number of shares of common stock outstanding as of the Company’s immediately preceding fiscal year, or (ii) a number of shares determined by the Board of Directors. The

GIGOPTIX, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

maximum number of common stock to be granted is up to 21,000,000 shares, respectively. Forfeited options or awards generally become available for future awards. The automatic increase on January 1, 2009 and January 1, 2010 was 258,661 and 464,505 shares, respectively. In addition, the Company’s Board of Directors and stockholders of the Company authorized an additional 3,000,000 shares effective January 20, 2010.

Under the 2008 Plan, the exercise price of (i) an award is at least 100% of the stock’s fair market value on the date of grant, and (ii) an ISO granted to a 10% stockholder is at least 110% of the stock’s fair market value on the date of grant. Vesting periods for awards are determined by the CEO and generally provide for stock options to vest over a four-year period and have a maximum life of ten years from the date of grant. As of October 3, 2010, 4,374,834 options to purchase common stock were outstanding and 1,680,481 options were available for issuance under the 2008 Plan.

The above number of outstanding options includes options which the Company’s Board of Directors approved on March 17, 2010 in the amount of 2,287,000 options issued to employees and consultants and 70,000 options to board members at an exercise price of $1.95 which was the closing price of GigOptix shares on the date of grant approval. 1,188,500 of these options will vest over 4 years with 25% vesting on the one year anniversary of the grant with the remaining options vesting at a rate of 1/36 per month over the remaining three years. The fair value per share of these options is $1.21, the total expense associated with these options is $1.4 million, and the amount of expense recognized for the three and nine months ended October 3, 2010 is $72,000 and $166,000, respectively. The remaining shares will vest as follows:

467,400 shares will vest on April 1, 2011 if the average share price during March 2011 is at or above $2.50. The fair value per share of these options is $1.05, the total expense associated with these options is $496,000, and the amount of expense recognized for the three and nine months ended October 3, 2010 is $93,000 and $221,000, respectively. These options will be amortized over one year.

467,400 shares will vest on April 1, 2012 if the average share price during March 2012 is at or above $3.50. The fair value per share of these options is $1.01, the total expense associated with these options is $477,000, and the amount of expense recognized for the three and nine months ended October 3, 2010 is $49,000 and $111,000, respectively. These options will be amortized over two years.

233,700 shares will vest on April 1, 2013 if the average share price during March 2013 is at or above $5.00. The fair value per share of these options is $1.01, the total expense associated with these options is $239,000, and the amount of expense recognized for the three and nine months ended October 3, 2010 is $16,000 and $37,000, respectively. These options will be amortized over three years.

In all cases, if the threshold share price is not met, then the options will be cancelled and returned to the pool.

Lumera 2000 and 2004 Stock Option Plan

In December 2008, in connection with the merger with Lumera, the Company assumed the existing Lumera 2000 Equity Incentive Plan, and the Lumera 2004 Stock Option Plan (the “Lumera Plan”). All unvested options granted under the Lumera Plan were assumed by the Company as part of the merger. All contractual terms of the assumed options remain the same, except for the converted number of shares and exercise price based on merger conversion ratio of 0.125. As of October 3, 2010, no additional options can be granted under the Lumera Plan and options to purchase a total of 154,320 shares of common stock were outstanding including employee stock options, restricted stock and employee stock purchase rights based on their estimated fair values. The fair value of equity-based awards is amortized on a straight-line basis over the requisite service period of the award which is generally the vesting period.

Warrants

As of October 3, 2010, the Company had a total of 2,182,038 warrants to purchase common stock outstanding under all warrant arrangements at a weighted average exercise price of $17.45.

GIGOPTIX, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Stock-Based Compensation Expense

The following table summarizes the Company’s stock-based compensation expense for the three and nine months ended October 3, 2010 and the three and nine months ended October 4, 2009:


	Three months ended				Nine months ended
	October 3, 2010		October 4, 2009		October 3, 2010		October 4, 2009
Cost of revenue	$	3	$	3	$	9	$	5
Research and development expense		125		55		327		154
Selling, general and administrative expense		234		157		853		418

	$	362	$	215	$	1,189	$	577

Management estimates expected forfeitures and it records compensation expense only for those equity awards expected to vest. When estimating forfeitures, the Company considers voluntary termination behavior as well as an analysis of actual option forfeitures.

As of October 3, 2010 and October 4, 2009, the total compensation cost related to unvested stock options under the Company’s equity compensation plan, but not yet recognized, was approximately $3.2 million and $1.2 million, respectively. This cost will be amortized on a straight-line basis over a weighted-average period of approximately 2.7 and 3.3 years, respectively.

The Company estimates the fair value of stock options granted which vest ratably over the required service period using a Black-Scholes option-pricing model. This model requires the input of highly subjective assumptions, including the options’ expected life and the price volatility of the Company’s underlying stock options. Actual volatility, expected lives, interest rates and forfeitures may be different than the Company’s assumptions, which would result in an actual value of the options being different than estimated. During the first quarter of 2010 the Company awarded stock option grants whose vesting is determined by a market condition. In this case the Company is required to calculate the fair value of these options using a lattice model which creates a distribution of share prices from which a point estimate is determined based on the characteristics of the distribution. Valuations using the lattice model require the same highly subjective assumptions as those required using Black-Scholes. Under both valuation methodologies, the fair value of stock option grants is amortized on a straight-line basis over the requisite service period of the awards, which is generally the vesting period.

The fair value of the Company’s stock options granted to employees was estimated using the following weighted-average assumptions. Options granted during the first quarter of 2010 were valued using both the Black-Scholes method as well as a lattice model as approximately 50% of the grant had a market condition associated with it. The assumptions used to value the options for the three and nine months ended October 3, 2010 and the three and nine months ended October 4, 2009 are as follows:


	Three months ended								Nine months ended
	Black-Scholes October 3, 2010			Lattice October 3, 2010		Black-Scholes October 4, 2009			Black-Scholes October 3, 2010			Lattice October 3, 2010			Black-Scholes October 4, 2009
Expected term		5 years			—		5 years			5 years			5 years			5 years
Expected volatility		75.0	%		—		75.0	%		75.0	%		75.0	%		75.0	%
Expected dividends	$	—		$	—	$	—		$	—		$	—		$	—
Risk-free interest rate		1.7	%		—		2.2	%		1.7% - 2.4	%		3.7	%		2.2	%
Weighted-average fair value	$	1.20		$	—	$	2.46		$	1.22		$	1.01 - $1.05		$	0.85

GIGOPTIX, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Stock Option Activity

The following is a summary of option activity for the Company’s equity incentive plans:


	Stock Options			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term
Outstanding, December 31, 2009		3,085,160		$	3.58
Granted		2,572,000			1.95
Exercised		(133,431	)		0.97
Forfeited/expired		(541,143	)		5.10
Ending balance, October 3, 2010		4,982,586		$	2.64		8.66 years

Exercisable, October 3, 2010		1,487,158		$	4.28		7.56 years

The aggregate intrinsic value of options outstanding and based on the fair value of the underlying stock options as of October 3, 2010 and October 4, 2009 was approximately $4.8 million and $6.1 million, respectively. The aggregate intrinsic value reflects the difference between the exercise price of the underlying stock options and the Company’s closing stock price of $2.55 as of October 3, 2010.

NOTE 8—INCOME TAXES

The Company recorded a benefit for income taxes of $2,000 and a provision for income taxes of $22,000 for the three months ended October 3, 2010 and October 4, 2009, respectively. The Company recorded a provision for income taxes of $22,000 and a benefit for income taxes of $107,000 for the nine months ended October 3, 2010, and October 4, 2009, respectively. The Company’s effective tax rate was 0% and 2% for the three months ended October 3, 2010 and October 4, 2009, respectively. The Company’s effective tax rate was 1% and (4%) for the nine months ended October 3, 2010 and October 4, 2009, respectively. The income tax provision for the three months ended October 4, 2009 and nine months ended October 3, 2010 was due primarily to state and foreign income taxes due and to losses in all tax jurisdictions and full valuation allowance against such losses. The benefit for income tax for the nine months ended October 4, 2009 was primarily due to losses in the Company’s Swiss subsidiary. The benefit for income tax for the three months ended October 3, 2010 was due primarily to a reduction in state and foreign income taxes due and to losses in all tax jurisdictions and full valuation allowance against such losses.

In assessing the potential realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will be realized. In making such a determination, management considers all available positive and negative evidence, including scheduled reversals of deferred tax liabilities, projected future taxable income, tax planning strategies and recent financial performance. In order to support a conclusion that a valuation allowance in not needed, positive evidence of sufficient quantity and quality is necessary to overcome negative evidence. The ultimate realization of deferred tax assets is dependent on the generation of future taxable income during the periods in which those temporary differences become deductible. A valuation allowance is recorded for the entire deferred tax asset as a result of uncertainties regarding realization of the asset including lack of profitability through October 3, 2010 and the uncertainty over future operating profitability and taxable income. We will continue to evaluate the potential realization of the deferred tax assets on a quarterly basis.

The Company is subject to income taxes in the U.S. federal jurisdiction and various foreign jurisdictions. All tax years since inception are open and may be subject to potential examination in one or more jurisdictions. The Company does believe that the ultimate settlement of any tax obligations will materially affect its liquidity.

NOTE 9—SEGMENT AND GEOGRAPHIC INFORMATION

The Company has determined that it operates as a single operating and reportable segment. The following tables reflect the results of the Company’s reportable segment consistent with the management system used by the Company’s chief operating decision maker. The Company’s Chief Executive Officer is the chief operating decision maker.

GIGOPTIX, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

The following table summarizes revenue by geographic region (in thousands):


	Three months ended				Nine months ended
	October 3, 2010		October 4, 2009		October 3, 2010		October 4, 2009
Asia	$	1,502	$	711	$	4,344	$	2,554
Europe		2,200		1,007		4,780		3,224
United States		3,521		1,429		9,521		5,912
South America		—		—		131		—

	$	7,223	$	3,147	$	18,776	$	11,690

The Company determines geographic location of its revenue based upon the destination of shipment of its products.

During the three months ended October 3, 2010, the United States, Italy and Japan accounted for 48%, 15% and 13% of total revenue, respectively. During the nine months ended October 3, 2010, the United States and Japan accounted for 50% and 10% of total revenue, respectively. During the three and nine months ended October 4, 2009, the United States, Italy, and Hong Kong accounted for 44%, 23%, and 11% and 50%, 24% and 12%, respectively of revenue, respectively. No other countries accounted for more than 10% of the Company’s consolidated revenue during the periods presented.

The following table summarizes long-lived assets by country (in thousands):


	October 3, 2010		December 31, 2009
United States	$	3,141	$	3,679
Switzerland		758		322
Israel		143		333

	$	4,042	$	4,334

Long-lived assets, comprising property and equipment, are reported based on the location of the assets at end of each period.

NOTE 10—COMMITMENTS AND CONTINGENCIES

Commitments

Leases

The Company leases its domestic and foreign sales offices under non-cancelable operating leases. These leases contain various expiration dates and renewal options. In January 2009, the Company renewed its lease for its office facility located at Palo Alto, California. The new lease term will expire in December 2013. In February 2010, the Company renewed its lease for its facility in Bothell, Washington at a reduced average monthly rate as it decreased its square footage under lease. The lease term began in April 2010 and will expire in March 2014. The Company also leases certain software licenses under operating leases. Total rental expense for the three and nine months ending October 3, 2010 was $0.1 million and $0.4 million, respectively. Total rental expense for the three and nine months ending October 4, 2009 was $0.3 million and $0.8 million, respectively.

GIGOPTIX, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Aggregate non-cancelable future minimum rental payments under capital and operating leases are as follows (in thousands):


Years ending December 31,	Capital Leases			Operating Leases
2010 (remaining period)	$	210		$	316
2011		402			706
2012		400			587
2013		400			589
2014		457			36

Total minimum lease payments	$	1,869		$	2,234

Less: Amount representing interest	$	(514	)
Present value of capital lease obligations	$	1,355
Less: current portion	$	293

Long-term portion of capital lease obligations	$	1,062

Contingencies

Tax Contingencies

In 2008, the Franchise Tax Board (FTB) completed its audit of the Company’s qualifying sales and use activity for 2004 through 2007 and has proposed an amount due. The Company received a notice from the FTB and was assessed $0.3 million, which represents principal and estimated interest and penalties. As a result, in the fourth quarter of 2008, the Company accrued $0.3 million in relation to the sales and use tax due for the period 2004 through 2007, and in June 2009, the Company paid approximately $0.2 million to the FTB. As of October 3, 2010 the Company has accrued the estimated sales and use tax payable relating to fiscal periods through the three and nine months ended October 3, 2010.

The Company’s income tax calculations are based on application of the respective U.S. Federal, state or foreign tax law. The Company’s tax filings, however, are subject to audit by the respective tax authorities. Accordingly, the Company recognizes tax liabilities based upon its estimate of whether, and the extent to which, additional taxes will be due.

Legal Contingencies

From time to time, we may become involved in legal proceedings, claims and litigation arising in the ordinary course of business. When we believe a loss is probable and can be reasonably estimated, we accrue the estimated loss in our consolidated financial statements. Where the outcome of these matters is not determinable, we do not make a provision in our financial statements until the loss, if any, is probable and can be reasonable estimated or the outcome becomes known.

In or about November 2008, an entity named DBSI Inc., which at the time was the beneficial owner of approximately 1.7 million shares of GigOptix common stock, filed for bankruptcy in the United States Bankruptcy Court for the District of Delaware (Case No. 08-12687 (PJW)). GigOptix understands the DBSI Estate Litigation Trustee is currently evaluating claims that it may assert against a number of entities, including GigOptix and/or its predecessors and affiliates. In November 2010, GigOptix entered into tolling agreements, which expire March 7, 2011, with the Trustee to allow the parties to continue discussions in an attempt to avoid litigation. Management has engaged in discussions with the Trustee and intends to vigorously defend any claims made against the Company.

NOTE 11—RELATED PARTY TRANSACTIONS

During the three and nine months ended October 3, 2010, we had sales to National Instruments of approximately $448,000 and $1.1 million, respectively. National Instruments currently holds 1,066,270 shares of GigOptix common stock.

GIGOPTIX, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

NOTE 12—RESTRUCTURING

In December 2009, the Company adopted a plan to reduce the size of its facilities in Bothell, Washington. The Company reduced the amount of square footage it occupies from approximately 32,000 square feet to approximately 12,000 square feet and took a restructuring charge of $0.5 million to reflect the proportionate share of remaining lease expense it will incur for the unoccupied space of the facility and costs associated with improvements needed to segregate the facility. The existing lease on the facility expires in March 2011. Although the Company has made available for sub-lease approximately 20,000 square feet, it does not anticipate it will receive any sub-lease income associated with this space prior to the lease expiration. Approximately $0.4 million will be paid out in 2010 with the balance to be paid in 2011. The company paid out approximately $105,000 and $352,000 related to unoccupied space in Bothell during the three and nine months ended October 3, 2010, respectively.

During the three months ended April 4, 2010 the Company decided to close its R&D design center in Haifa, Israel which was acquired as part of the merger with ChipX in 2009. The Company took a restructuring charge of $428,000 to account for employee severance of $196,000, future facility rent expense of $61,000 for the remainder of the lease term through the end of fiscal 2010, a write-down of fixed assets of $121,000, and accounting and legal expenses of $50,000. All cash payments will occur during fiscal 2010. The Company paid out approximately $14,000 and $208,000, respectively, during the three and nine months ended, October 3, 2010, respectively, related to the restructuring.


				Israel Restructuring
	Bothell Excess Space			Severance			Facilities			Equipment Write-down			Legal/Acctg			Total
Balance, December 31, 2009	$	424		$	—		$	—		$	—		$	—		$	424
Q1 2010 Charges		—			196			61			121			50			428
Q1 2010 Uses		(144	)		—			—			(121	)		—			(265	)
Balance, April 4, 2010	$	280		$	196		$	61		$	—		$	50		$	587

Q2 2010 Charges		—			—			—			—			—			—
Q2 2010 Uses		(103	)		(146	)		(36	)		—			(12	)		(297	)
Balance, July 4, 2010	$	177		$	50		$	25		$	—		$	38		$	290

Q3 2010 Charges		—			—			—			—			—			—
Q3 2010 Uses		(105	)		11			(25	)		—			—			(119	)
Balance, October 3, 2010	$	72		$	61		$	—		$	—		$	38		$	171

ITEM 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

You should read the following discussion and analysis in conjunction with our consolidated financial statements and the related notes included elsewhere in our Annual Report on Form 10-K for the year ended December 31, 2009. This discussion and analysis contains forward-looking statements that involve risks, uncertainties, and assumptions. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of certain factors, including, but not limited to, those set forth under “Risk Factors” and elsewhere in our Annual Report on Form 10-K for the year ended December 31, 2009 and this Quarterly Report on Form 10-Q. We assume no obligation to update the forward-looking statements or such risk factors.

This Quarterly Report on Form 10-Q and the documents incorporated herein by reference include “forward-looking statements” within the meaning and protections of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. These forward-looking statements area lso made in reliance upon the safe harbor provision of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements with respect to our beliefs, plans, objectives, goals, expectations, anticipations, assumptions, estimates, intentions, and future performance, and involve known and unknown risks, uncertainties and other factors, which may be beyond our control, and which may cause our actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements.

Overview

We are a leading supplier of electronic and electro-optic semiconductor products that enable high speed telecommunications, or telecom, and data-communications, or data-com, networks. Our products amplify, process, drive, convert and modulate signals between electrical and optical formats for transmission and reception of voice, data and video, enabling global network providers to offer “triple play” and other enhanced information streaming services. We have a history of innovation in designing and bringing to market unique technologies in 10Gbps, 40Gbps and the emerging 100Gbps standards, both in parallel and serial applications, spanning from short reach consumer electronics, datacenter applications up through ultra long-haul submarine networks. Our digital, analog and mixed-signal integrated circuit (IC) products include high power precision drivers, broadband amplifiers, low noise receivers, mixed-signal integrated circuits, and monolithic microwave integrated circuits, and we recently introduced electro-optical thin film polymer on silicon (TFPS) modulators for ultra-broadband applications. These products offer our customers numerous benefits over those of our competitors including the ability to operate at higher speeds and over wider temperature ranges, consume less power at peak loads, offer a smaller footprint and a lower cost compared to other products. We have a global customer base including leading telecommunications and data-communications network equipment systems vendors such as Alcatel-Lucent, Coreoptics (now a division of Cisco), Finisar, Fujitsu, Mitsubishi, Opnext, Source Photonics, ZTE, and other “Tier-One” equipment vendors in the United States, Europe and Asia, as well as leading industrial, aerospace and defense customers such as Boeing, National Instruments, Northrop Grumman, Raytheon and Rockwell-Collins.

We operate as a fabless company, which means that we outsource the manufacturing of silicon wafers, and believe we have positioned ourselves uniquely given our ability to offer the three key components in a transponder, namely, TFPS-modulators, matching drivers, and receiver amplifiers, thereby solving the challenging issue of component interoperability and allowing a more highly integrated and durable product at a smaller foot print and lower cost.

Our recent acquisition of ChipX, Incorporated (ChipX), whose products now comprise our CX product line, enables us to develop and market custom application specific integrated circuits (ASICs) based on our proprietary Structured ASIC and Hybrid ASIC platforms. We have over 60 different designs encompassing analog-to-digital converters (ADCs), digital-to-analog converters (DACs), regulators and various power management functions. These products allow us to enhance our product offerings to our telecom and data-com network customers, as well as cross-sell our optical components to our CX defense and aerospace customers. In 2009, we sold our products to over 75 customers globally.

GigOptix, Inc. (GigOptix or the Company), the successor to GigOptix LLC, was formed as a Delaware corporation in March 2008 in order to facilitate a combination between GigOptix LLC and Lumera Corporation (Lumera). Before the combination, GigOptix LLC acquired the assets of iTerra Communications LLC in July 2007 (iTerra) and Helix Semiconductors AG (Helix) in January 2008. On November 9, 2009, GigOptix acquired ChipX. As a result of the acquisitions, Helix, Lumera and ChipX all became wholly owned subsidiaries of GigOptix.

Recent Accounting Pronouncements

Results of Operations

Revenue

Revenue for the periods reported was as follows (in thousands, except percentages):


	Three months ended					Nine months ended
	October 3, 2010			October 4, 2009		October 3, 2010			October 4, 2009
Product	$	5,866		$	2,142	$	16,525		$	7,582
Government contract		1,357			1,005		2,251			4,108

Total revenue	$	7,223		$	3,147	$	18,776		$	11,690
Increase period over period	$	4,076				$	7,086
Percentage increase, period over period		130	%				61	%

Revenue for the three months ended October 3, 2010 was $7.2 million, an increase of $4.1 million or 130% compared with $3.1 million for the three months ended October 4, 2009. The increase in revenue of $4.1 million was primarily due to an increase in product revenue of $3.7 million, which includes increased revenue from our 40G and 100G optical products, revenues derived from ChipX, which we acquired in November 2009, and an increase in billings under government contracts of $0.4 million.

Revenue for the nine months ended October 3, 2010 was $18.8 million, an increase of $7.1 million or 61% compared with $11.7 million for the nine months ended October 4, 2009. The increase in revenue of $7.1 million was primarily due to an increase in product revenue of $9.0 million, which includes increased revenue from our 40G and 100G optical products, revenues derived from ChipX, which we acquired in November 2009, offset by a reduction in billings under government contracts of $1.9 million.

Gross Profit

Gross profit consists of revenue, less cost of revenue, which includes amortization of certain identified intangible assets. Cost of revenue consists primarily of the manufacture of saleable chips, including outsourced wafer fabrication and testing. Amortization expense of identified intangible assets, namely existing technology, is presented within of cost of revenue, as the intangible assets were determined to be directly attributable to revenue generating activities.

Cost of revenue and gross profit for the periods presented was as follows (in thousands, except percentages):


Cost of Revenue	Three months ended						Nine months ended
	October 3, 2010			October 4, 2009			October 3, 2010			October 4, 2009
Product	$	3,106		$	964		$	8,329		$	3,100
Government contract		305			367			557			1,765

Total cost of revenue	$	3,411		$	1,331		$	8,886		$	4,865
Percentage of revenue		47	%		42	%		47	%		42	%
Increase period over period	$	2,080					$	4,021
Percentage increase, period over period		156	%					83	%

Gross Profit	Three months ended						Nine months ended
	October 3, 2010			October 4, 2009			October 3, 2010			October 4, 2009
Product	$	2,760		$	1,178		$	8,196		$	4,482
Government contract		1,052			638			1,694			2,343

Total gross profit	$	3,812		$	1,816		$	9,890		$	6,825
Gross margin		53	%		58	%		53	%		58	%
Increase, period over period	$	1,996					$	3,065
Percentage increase, period over period		110	%					45	%

Gross profit for the three months ended October 3, 2010 was $3.8 million, or 53% of revenue, an increase of $2.0 million or 110% as compared to a gross profit of $1.8 million, or 58% of revenue, for the three months ended October 4, 2009. The increase in gross profit in the three months ended October 3, 2010 compared to the three months ended October 4, 2009 is due to the $4.1 million increase in revenue, which results primarily from the Company’s acquisition of ChipX. The decrease in gross margin results primarily from the impact on gross margin of a low margin product line acquired as part of the ChipX transaction, offset by a decrease in overhead allocation to cost of revenue associated with our government contract revenue.

Gross profit for the nine months ended October 3, 2010 was $9.9 million, or 53% of revenue, an increase of $3.1 million or 45% as compared to a gross profit of $6.8 million, or 58% of revenue, for the nine months ended October 4, 2009. The increase in gross profit in the nine months ended October 3, 2010 compared to the nine months ended October 4, 2009 is due to the $7.1 million increase in revenue, which results primarily from the Company’s acquisition of ChipX. The decrease in gross margin results primarily from a $0.6 million decrease in government billings which normally carry a higher margin percentage compared to product revenue and the impact on gross margin of a low margin product line acquired as part of the ChipX transaction.

Research and Development Expense

Research and development expenses are expensed as incurred. Research and development costs consist primarily of consulting and engineering design, non-capitalized tools and equipment, equipment depreciation and employee compensation.

Research and development expense for the periods presented was as follows (in thousands, except percentages):


	Three months ended						Nine months ended
	October 3, 2010			October 4, 2009			October 3, 2010			October 4, 2009
Research and development expense	$	1,852		$	1,255		$	6,056		$	3,919
Percentage of revenue		26	%		40	%		32	%		34	%
Increase, period over period	$	597					$	2,137
Percentage increase, period over period		48	%					55	%

Research and development expense for the three months ended October 3, 2010 was $1.9 million compared to $1.3 million for the three months ended October 4, 2009, an increase of $597,000 or 48%. The increase in research and development expense primarily resulted from increased spending associated with higher investments in new product development across all product lines and included increases in employee salaries and benefits of $493,000, stock based compensation expense of $69,000 and amortization of licenses of $42,000.

Research and development expense for the nine months ended October 3, 2010 was $6.1 million compared to $3.9 million for the nine months ended October 4, 2009, an increase of $2.1 million or 55%. The increase in research and development expense primarily resulted from increased spending associated with higher investments in new product development across all product lines as well as certain costs being recorded as research and development resulting from reduced government contract billings. Research and development expenditures that are directly related to government projects are classified as cost of revenue against those government contracts; resources that are not being applied to government contracts are charged to research and development expense.

Selling, General and Administrative Expense

Selling, general and administrative expenses consist primarily of salaries and benefits for management, marketing and administration personnel, as well as fees for consultants.

Selling, general and administrative expense for the periods presented was as follows (in thousands, except percentages):


	Three months ended						Nine months ended
	October 3, 2010			October 4, 2009			October 3, 2010			October 4, 2009
Selling, general and administrative expense	$	2,247		$	1,744		$	6,921		$	6,170
Percentage of revenue		31	%		55	%		37	%		53	%
Increase period over period	$	503					$	751
Percentage increase, period over period		29	%					12	%

Selling, general and administrative expense for the three months ended October 3, 2010 was $2.2 million compared to $1.7 million for the three months ended October 4, 2009, an increase of $503,000 or 29%. This increase was primarily due to an increase in employee related expenses in connection with our recent acquisitions such as salaries and benefits of approximately $350,000 and an increase in stock based compensation expense of $116,000 and higher levels of activity associated with expanding our global presence, primarily in Asia.

Selling, general and administrative expense for the nine months ended October 3, 2010 was $6.9 million compared to $6.2 million for the nine months ended October 4, 2009, an increase of $751,000 or 12%. This increase is primarily due to an increase in stock based compensation expense of $519,000, an increase in employee salaries and benefits of $315,000, an increase in legal fees of $175,000 and an increase of $152,000 associated with the amortization of intangible assets associated with the ChipX acquisition. These increases were offset by decreases in accounting fees of $303,000 and consulting expenses of $103,000.

Restructuring Expense

Restructuring expense for the periods presented was as follows (in thousands):


	Three months ended				Nine months ended
	October 3, 2010		October 4, 2009		October 3, 2010		October 4, 2009
Restructuring expense	$	—	$	—	$	428	$	—

During the three months ended October 3, 2010 and October 4, 2009, the Company did not incur any restructuring expense.

During the nine months ended October 3, 2010 the Company decided to close its R&D design center in Haifa, Israel which was acquired as part of the merger with ChipX in 2009. The Company took a restructuring charge of $428,000 to account for employee severance of $196,000, future facility rent expense of $61,000 for the remainder of the lease term through the end of fiscal 2010, a write-down of fixed assets of $121,000, and accounting and legal expenses of $50,000. All cash payments will occur during fiscal 2010.

During the three and nine months ended October 3, 2010, the Company made cash payments of $119,000 and $560,000 related to the restructuring of its facility in Bothell, Washington and its R&D design center in Haifa, Israel.

Other Expense, Net and Interest Expense, Net

Other expense, net and interest expense, net for the periods presented were as follows (in thousands, except percentages):


	Three months ended					Nine months ended
	October 3, 2010			October 4, 2009		October 3, 2010			October 4, 2009
Interest expense, net	$	(105	)	$	—	$	(335	)	$	(2	)
Other expense, net		(16	)		8		(132	)		338

Total	$	(121	)	$	8	$	(467	)	$	336

Interest expense, net for the three months ended October 3, 2010 increased by $105,000 as compared to the three months ended October 4, 2009. The increase is due primarily to an increase in interest expense of $51,000 related to the Company’s line of credit with Silicon Valley Bank, $46,000 associated with capital leases and $7,000 associated with a term loan with Silicon Valley Bank.

Other expense, net for the three months ended October 3, 2010 increased by $24,000 due to foreign currency losses of $18,000 and a reduction in other income of $6,000.

Interest expense, net for the nine months ended October 3, 2010 increased by $333,000 as compared to the nine months ended October 4, 2009. The increase is driven by $95,000 resulting from interest on the Company’s line of credit with Silicon Valley Bank, $54,000 from the amortization of the discount on the Bridge Bank loan, $143,000 from a capital lease for CAD tools, and the remaining $41,000 resulting from interest expense incurred as a result of additional borrowings with Bridge Bank, Agility Capital and Silicon Valley Bank.

Other income (expense), net for the nine months ended October 3, 2010 decreased by approximately $470,000, primarily due to the sale of the assets of Plexera Bioscience LLC during the nine months ended October 4, 2009. The assets were sold “as is” to Plexera, LLC, a newly formed company, for $300,000 and the Company recorded a gain of $300,000 which was included in “Other income (expense), net” for the nine months ended October 4, 2009. The Company has not received any further consideration from the sale of the Plexera assets as of October 3, 2010.

In addition, during the nine months ended October 3, 2010 the Company also incurred $98,000 in amortization expense associated with the discount on the Bridge Bank loan as well as approximately $29,000 in foreign currency transaction losses.

Benefit from (Provision for) Income Taxes

The benefit for income taxes was $2,000 for the three months ended October 3, 2010 was due primarily to a reduction in state and foreign income taxes due and to losses in all tax jurisdictions and a full valuation allowance against such losses. The provision for income taxes was $22,000 for the three months ended October 4, 2009 and was due primarily to state and foreign income taxes due and losses in all tax jurisdictions and full valuation against such losses. The effective tax rate was 0% and 2% for the three months ended October 3, 2010 and October 4, 2009, respectively.

The provision for income taxes was $22,000 for the nine months ended October 3, 2010 and the benefit from income taxes was $107,000 for the nine months ended October 4, 2009, respectively. The effective tax rate was 1% and (4%) for the nine months ended October 3, 2010 and October 4, 2009, respectively. The income tax provision during the nine months ended October 3, 2010 was due primarily to state and foreign income taxes due and losses in all tax jurisdictions and full valuation against such losses. The benefit from income taxes during the nine months ended October 4, 2009 was primarily due to losses in the Company’s Swiss subsidiary.

Liquidity and Capital Resources

Cash and cash equivalents and cash flow data for the periods presented were as follows (in thousands):


	October 3, 2010			October 4, 2009
Cash and cash equivalents	$	4,852		$	2,814

	Nine months ended
	October 3, 2010			October 4, 2009
Net cash used in operating activities	$	(3,680	)	$	(3,158	)
Net cash provided by (used in) investing activities	$	(771	)	$	(127	)
Net cash provided by (used in) financing activities	$	5,715		$	(783	)

In July 2010, we sold 2,760,000 shares of common stock in a public offering at a price of $1.75 per share. Gross proceeds from the sale were $4.83 million from which we received net proceeds of $3.9 million after deducting total expenses of the offering.

On April 23, 2010, we entered into a loan and security agreement with Silicon Valley Bank. Pursuant to the loan and security agreement, we are entitled to borrow through a revolving loan facility from Silicon Valley Bank up to $3 million, based on net eligible accounts receivable after an 80% advance rate and subject to limits based on our eligible accounts as determined by Silicon Valley Bank. Interest on extensions of credit under the revolving loan is equal to the prime rate of Silicon Valley Bank, which is currently 4.0% per annum, plus 1.50% per annum (the Applicable Rate). In addition, a monthly collateral handling fee of 0.30% per each gross financed account receivable shall apply (Collateral Handing Fee). Notwithstanding the foregoing, if we achieve certain quarterly financial performance targets as stated in the loan and security agreement, the Applicable Rate and the Collateral Handling Fee shall be reduced to the prime rate of Silicon Valley Bank plus 1.0% per annum and 0.20% respectively. The revolving loan was used to replace our revolving accounts receivable credit line with Bridge Bank which is discussed below. With the initial funding by Silicon Valley Bank of the revolving loan, we terminated our loan and security agreement with Bridge Bank as having been fully performed.

Pursuant to the loan and security agreement, Silicon Valley Bank also is making available a term loan in an amount up to $400,000, subject to the satisfaction of terms and conditions of the loan and security agreement, which can be drawn down one time for the purpose of refinancing our outstanding obligations to Agility Capital (we previously disclosed these obligations to Agility Capital on our Current Report on Form 8-K filed on February 4, 2010). The term loan is repayable in eighteen equal monthly installments and interest is fixed at a rate per annum equal to 9.00%. With the funding by Silicon Valley Bank of the Term Loan, we terminated our loan agreement with Agility Capital.

The loan and security agreement with Silicon Valley Bank is secured by all of the Company’s assets , including all accounts, equipment, inventory, receivables, and general intangibles.

In November 2009, we entered into a loan and security agreement with Bridge Bank under which we could borrow up to $4,000,000, based on net eligible accounts receivable. Borrowings under the line of credit bore interest at the bank’s prime rate plus 2.50% (6.50% as of December 31, 2009), provided that in no event would the prime rate be less than 4.00%. Borrowings under the line were collateralized by a security interest in all of our assets. At December 31, 2009, the amount outstanding under the line of credit was approximately $1.3 million, which is classified within current liabilities.

Operating Activities

Operating activities used cash of $3.7 million in the nine months ended October 3, 2010. This resulted from a net loss of $4.0 million, increases in accounts receivables, inventories, prepaid expenses and other current assets totaling $1.1 million, and decreases in accounts payable and accrued liabilities of $2.5 million. These uses were partially offset by the following non-cash expenses: depreciation and amortization of $2.0 million, stock based compensation of $1.2 million, a fixed asset write down of $121,000, the amortization of an acquisition related payment of $450,000 and the amortization of a discount on loan of $152,000.

Operating activities used cash of $3.2 million in the nine months ended October 4, 2009. This resulted from a net loss of $2.8 million, increases in accounts receivable of $0.5 million, decreases in accrued and other current liabilities of $1.2 million, a gain on the sale of assets of $300,000, and deferred taxes of $83,000. These uses were partially offset by non cash expenses for depreciation and amortization of $685,000, stock based compensation of $577,000 and the amortization of an acquisition related payment of $525,000.

Investing Activities

Net cash used in investing activities for the nine months ended October 3, 2010 was $771,000 and consisted of purchases of fixed assets of $971,000 offset by a reduction in restricted cash of $200,000.

Net cash used in investing activities for the nine months ended October 4, 2009 was $127,000 and consisted of $300,000 of proceeds received from the sale of Plexera assets offset by fixed asset purchases of $427,000.

Financing Activities

Net cash provided by financing activities was $5.7 million during the nine months ended October 3, 2010 and consisted of $4.1 million in proceeds from the issuance of common stock and warrants, including $3.9 million in proceeds from our public offering in July 2010 , net borrowings under the Company’s line of credit facilities with Bridge Bank and Silicon Valley Bank of $1.5 million, net borrowings of $321,000 under a term loan arrangement with Agility Capital subsequently refinanced by Silicon Valley Bank offset by capital lease payments of $157,000.

Net cash used by financing activities during the nine months ended October 4, 2009 was $783,000 and consisted primarily of the net repayment of the line of credit with Silicon Valley Bank. All of the Company’s financing activities are denominated in U.S. dollars so there is no impact from changes in foreign currency exchange rates.

ITEM 4T.

CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Based on an evaluation under the supervision and with the participation of the Company’s management, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that, due to the material weaknesses disclosed in its Annual Report on Form 10-K for the year ended December 31, 2009 that remain unremediated, the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended), were not effective as of October 3, 2010. As a result of this conclusion, the financial statements for the periods covered by this report were prepared with particular attention to the material weaknesses previously disclosed. Accordingly, management believes that the condensed consolidated financial statements included in this Quarterly Report fairly present, in all material respects, the Company’s financial condition, results of operations and cash flows as of and for the periods presented.

Changes in Internal Control

During the nine month period ended October 3, 2010, the Company continued to implement its remediation plan in response to the material weaknesses discussed in our annual report on Form 10-K for the year ended December 31, 2009. While the Company’s effort to remediate its material weakness is ongoing, it is in the initial stages of executing its remediation plan. Accordingly, the Company does not believe that its material weaknesses have been fully remediated, or that the changes made to its internal control over financial reporting during the nine month period ended October 3, 2010 have materially affected, or are reasonably likely to materially affect, its internal control over financial reporting.

We are investing in ongoing efforts to continuously improve the control environment and have committed considerable resources to the continuous improvement of the design, implementation, documentation, testing, and monitoring of our internal controls. In addition to improving the effectiveness and compliance with key controls, our remediation efforts involve ongoing business and accounting process improvements and the implementation of key system enhancements. The process and system enhancements are generally designed to simplify and standardize business practices and to improve timeliness and access to associated accounting data through increased systems automation, appropriate limitations around IT access as well as timely testing of controls throughout the year. While we expect remedial actions to be essentially implemented in 2010, some actions may not be in place for a sufficient period of time to help us certify that material weaknesses have been fully remediated as of the end of 2010. We will continue to develop our remediation plans and implement additional measures during 2010 and possibly into 2011.

PART II

OTHER INFORMATION

ITEM 1.

LEGAL PROCEEDINGS

In or about November 2008, an entity named DBSI Inc., which at the time was the beneficial owner of approximately 1.7 million shares of GigOptix common stock, filed for bankruptcy in the United States Bankruptcy Court for the District of Delaware (Case No. 08-12687 (PJW)). GigOptix understands the DBSI Estate Litigation Trustee is currently evaluating claims that it may assert against a number of entities, including GigOptix and/or its predecessors and affiliates. In November 2010, GigOptix entered tolling agreements, which expire March 7, 2011, with the Trustee to allow the parties to continue discussions in an attempt to avoid litigation. Management has engaged in discussions with the Trustee and intends to vigorously defend any claims made against the Company.

ITEM 1A.

RISK FACTORS

We have revised the risk factors that relate to our business, as set forth below. These risks include any material changes to and supersede the risks previously disclosed in Part I, Item 1A in our Annual Report on Form 10-K for the year ended December 31, 2009. We encourage investors to review the risk factors and uncertainties relating to our business disclosed in that Form 10-K, as well as those contained in Part 1, Item 2, Management’s Discussion and Analysis of Financial Condition and Results of Operations, above.

We and our predecessors have incurred substantial operating losses in the past and we may not be able to achieve profitability in the future.

We have incurred negative cash flows from operations since inception. We incurred a net loss of $4.0 million for the nine months ended October 3, 2010 and for the years ended December 31, 2009 and 2008, we incurred net losses of $10.0 million and $7.7 million, respectively, and cash outflows from operations of $4.1 million and $6.7 million, respectively. As of October 3, 2010, we had an accumulated deficit of $73.0 million. We expect development, sales and other operating expenses to increase in the future as we expand our business. If our revenue does not grow to offset these expected increased expenses, we may not be profitable. In fact, in future quarters we may not have any revenue growth and our revenues could decline. Furthermore, if our operating expenses exceed expectations, financial performance will be adversely affected and we may continue to incur significant losses in the future.

In addition, we acquired ChipX in November 2009, which incurred net losses of $5.7 million for the year ended December 31, 2008 and an additional net loss of $3.3 million for the period from January 1, 2009 through the date of acquisition of November 9, 2009.

We will require additional capital to continue to fund our operations. If we do not obtain additional capital, we may be required to substantially limit operations.

We do not expect to generate sufficient cash needed to finance our anticipated operations for the foreseeable future from such operations. Accordingly, we will need to seek funding through public or private financings, including equity financings, and through other arrangements including collaborations. We could require additional financing sooner than expected if we have poor financial results, including unanticipated expenses, or an unanticipated drop in projected revenues. Such financing may be unavailable when needed or may not be available on acceptable terms. If we raise additional funds by issuing equity or convertible debt securities, the percentage ownership of our current stockholders will be reduced, and these securities may have rights superior to those of our common stock. If adequate funds are not available to satisfy either short-term or long-term capital requirements, or if planned revenues are not generated, we may be required to limit our operations substantially. These limitations of operations may include a possible sale or shutdown of portions of our business, reductions in capital expenditures and reductions in staff and discretionary costs.

We may fail to realize the anticipated benefits of our mergers with ChipX and Lumera.

Our future success will depend in significant part on our ability to realize the cost savings, operating efficiencies and new revenue opportunities that are expected to result from the integration of the GigOptix, Lumera and ChipX businesses. Our operating results and financial condition will be adversely affected if we are unable to integrate successfully the operations of GigOptix, Lumera and ChipX, fail to achieve or achieve on a timely basis such cost savings, operating efficiencies and new revenue opportunities, or incur unforeseen costs and expenses or

experience unexpected operating difficulties that offset anticipated cost savings. In particular, the integration of GigOptix, Lumera and ChipX may involve, among other matters, integration of sales, marketing, billing, accounting, quality control, management, personnel, payroll, regulatory compliance, network infrastructure and other systems and operating hardware and software, some of which may be incompatible and therefore may need to be replaced.

Any estimates of cost savings are based upon our assumptions concerning a number of factors, including operating efficiencies, the consolidation of functions, and the integration of operations, systems, marketing methods and procedures. These assumptions are uncertain and are subject to significant business, economic and competitive conditions that are difficult to predict and are often beyond our control.

Integrating the GigOptix and ChipX businesses may divert management’s attention away from our operations.

Successful integration of the operations, products and personnel of GigOptix and ChipX places a significant burden on our management and internal resources. The diversion of management’s attention and any difficulties encountered in the transition and integration process could harm our business, financial condition and operating results. The integration does require efforts from each company, including the coordination of general and administrative functions. For example, integration of administrative functions includes coordinating employee benefits, payroll, financial reporting, purchasing and disclosure functions. Delays in successfully integrating and managing employee benefits could lead to employee dissatisfaction and turnover. Problems in integrating purchasing and financial reporting could result in internal control issues, including unplanned costs. In addition, the combination of the GigOptix and ChipX businesses may result in greater competition for resources and elimination of product development programs that might otherwise be successfully completed.

Our strategy of growth through acquisition could harm our business.

It is our intent to continue to grow through strategic acquisitions. Successful integration of newly acquired target companies may place a significant burden on our management and internal resources. The diversion of management’s attention and any difficulties encountered in the transition and integration processes could harm our business, financial condition and operating results. In addition, we may be unable to execute our acquisition strategy, resulting in under-utilized resources and a failure to achieve anticipated growth.

We face intense competition and expect competition to increase in the future, which could have an adverse effect on our revenue, revenue growth rate, if any, and market share.

The global semiconductor market in general is highly competitive. We compete in different target markets to various degrees on the basis of a number of principal competitive factors, including our products’ performance, features and functionality, energy efficiency, size, ease of system design, customer support, products, reputation, reliability and price, as well as on the basis of our customer support, the quality of our product roadmap and our reputation. We expect competition to increase and intensify as more and larger semiconductor companies as well as the internal resources of large, integrated original equipment manufacturers, or OEMs, enter our markets. Increased competition could result in price pressure, reduced profitability and loss of market share, any of which could materially and adversely affect our business, revenue, revenue growth rates and operating results.

Our competitors range from large, international companies offering a wide range of semiconductor products to smaller companies specializing in narrow markets and internal engineering groups within device manufacturers, some of which may be our customers. Our primary competitors include Triquint, Vitesse, Oki, Inphi and Gennum. We expect competition in the markets in which we participate to increase in the future as existing competitors improve or expand their product offerings. In addition, we believe that a number of other public and private companies are in the process of developing competing products for digital television and other broadband communication applications. Because our products often are “building block” semiconductors which provide functions that in some cases can be integrated into more complex integrated circuits, we also face competition from manufacturers of integrated circuits, some of which may be existing customers that develop their own integrated circuit products.

Our ability to compete successfully depends on elements both within and outside of our control, including industry and general economic trends. During past periods of downturns in our industry, competition in the markets in which we operate intensified as manufacturers of semiconductors reduced prices in order to combat production overcapacity and high inventory levels. Many of our competitors have substantially greater financial and other resources with which to withstand similar adverse economic or market conditions in the future. Moreover, the competitive landscape is changing as a result of consolidation within our industry as some of our competitors have merged with or been acquired by other competitors, and other competitors have begun to collaborate with each other. These developments may materially and adversely affect our current and future target markets and our ability to compete successfully in those markets.

If we fail to develop and introduce new or enhanced products on a timely basis, our ability to attract and retain customers could be impaired and our competitive position could be harmed.

We operate in a dynamic environment characterized by rapidly changing technologies and industry standards and technological obsolescence. To compete successfully, we must design, develop, market and sell new or enhanced products that provide increasingly higher levels of performance and reliability and meet the cost expectations of our customers. The introduction of new products by our competitors, the market acceptance of products based on new or alternative technologies, or the emergence of new industry standards could render our existing or future products obsolete. Our failure to anticipate or timely develop new or enhanced products or technologies in response to technological shifts could result in decreased revenue. In particular, we may experience difficulties with product design, manufacturing, marketing or certification that could delay or prevent our development, introduction or marketing of new or enhanced products. If we fail to introduce new or enhanced products that meet the needs of our customers or penetrate new markets in a timely fashion, we will lose market share and our operating results will be adversely affected.

We rely on a limited number of third parties to manufacture, assemble and test our products, and the failure to manage our relationships with our third-party contractors successfully could adversely affect our ability to market and sell our products.

We do not have our own manufacturing facilities. We operate an outsourced manufacturing business model that utilizes third-party foundry and assembly and test capabilities. As a result, we rely on third-party foundry wafer fabrication and assembly and test capacity, including sole sourcing, for many components or products. Currently, our semiconductor devices are manufactured by foundries operated by IBM, Win, UMC and SEI. We also use third-party contractors for all of our assembly and test operations, including Bourns, Speel and SCI Sanmina.

Relying on third party manufacturing, assembly and testing presents significant risks to us, including the following:

•

failure by us, or our customers or their end customers to qualify a selected supplier;

•

capacity shortages during periods of high demand;

•

reduced control over delivery schedules and quality;

•

shortages of materials and potential lack of adequate capacity during periods of excess demand;

•

misappropriation of our intellectual property;

•

limited warranties on wafers or products supplied to us;

•

potential increases in prices;

•

inadequate manufacturing yields and excessive costs;

•

difficulties selecting and integrating new subcontractors; and

•

potential instability in countries where third-party manufacturers are located.

The ability and willingness of our third-party contractors to perform is largely outside our control. If one or more of our contract manufacturers or other outsourcers fails to perform its obligations in a timely manner or at satisfactory quality levels, our ability to bring products to market and our reputation could suffer. For example, in the event that manufacturing capacity is reduced or eliminated at one or more facilities, including as a response to the recent worldwide decline in the semiconductor industry, manufacturing could be disrupted, we could have difficulties fulfilling our customer orders and our net revenue could decline. In addition, if these third parties fail to deliver quality products and components on time and at reasonable prices, we could have difficulties fulfilling our customer orders, our net revenue could decline and our business, financial condition and results of operations would be adversely affected.

We do not have any long-term supply contracts with our contract manufacturers or suppliers, and any disruption in our supply of products or materials could have a material adverse affect on our business, revenue and operating results.

We currently do not have long-term supply contracts with any of our third-party vendors. We make substantially all of our purchases on a purchase order basis, and our contract manufacturers are not required to supply us products for any specific period or in any specific quantity. We expect that it would take approximately nine to twelve months to transition performance of our foundry or assembly services to new providers. Such a transition would likely require a qualification process by our customers or their end customers. We generally place orders for products with some of our suppliers approximately four to five months prior to the anticipated delivery date, with order volumes based on our forecasts of demand from our customers. Accordingly, if we inaccurately forecast demand for our products, we may be unable to obtain adequate and cost-effective foundry or assembly capacity from our third-party contractors to meet our customers’ delivery requirements, or we may accumulate excess inventories. Our third-party contractors have not provided any assurance to us that adequate capacity will be available to us within the time required to meet additional demand for our products.

Average selling prices of our products could decrease rapidly, which could have a material adverse effect on our revenue and gross margins.

We may experience substantial period-to-period fluctuations in future operating results due to the erosion of our average selling prices. From time to time, we have reduced the average unit price of our products in anticipation of competitive pricing pressures, new product introductions by us or our competitors and for other reasons. We expect that we will have to do so again in the future. If we are unable to offset any reductions in our average selling prices by increasing our sales volumes or introducing new products with higher operating margins, our revenue and gross margins will suffer. To maintain our gross margins, we must develop and introduce new products and product enhancements on a timely basis and continually reduce our and our customers’ costs. Failure to do so would cause our revenue and gross margins to decline.

Due to our limited operating history, we may have difficulty accurately predicting our future revenue and appropriately budgeting our expenses.

We were incorporated in 2008 and have only a limited operating history from which to predict future revenue. This limited operating experience, combined with the rapidly evolving nature of the markets in which we sell our products, substantial uncertainty concerning how these markets may develop and other factors beyond our control, reduces our ability to accurately forecast quarterly or annual revenue. We are currently expanding our staffing and increasing our expense levels in anticipation of future revenue growth. If our revenue does not increase as anticipated, we could incur significant losses due to our higher expense levels if we are not able to decrease our expenses in a timely manner to offset any shortfall in future revenue.

Our customers require our products and our third-party contractors to undergo a lengthy and expensive qualification process which does not assure product sales.

Prior to purchasing our products, our customers require that both our products and our third-party contractors undergo extensive qualification processes, which involve testing of the products in the customer’s system and rigorous reliability testing. This qualification process may continue for six months or more. However, qualification of a product by a customer does not assure any sales of the product to that customer. Even after successful qualification and sales of a product to a customer, a subsequent revision to the product, changes in our customer’s manufacturing process or our selection of a new supplier may require a new qualification process, which may result in delays and in us holding excess or obsolete inventory. After our products are qualified, it can take an additional six months or more before the customer commences volume production of components or devices that incorporate our products. Despite these uncertainties, we devote substantial resources, including design, engineering, sales, marketing and management efforts, to qualifying our products with customers in anticipation of sales. If we are unsuccessful or delayed in qualifying any of our products with a customer, sales of this product to the customer may be precluded or delayed, which may impede our growth and cause our business to suffer.

We are subject to order and shipment uncertainties, and differences between our estimates of customer demand and product mix and our actual results could negatively affect our inventory levels, sales and operating results.

Our revenue is generated on the basis of purchase orders with our customers rather than long-term purchase commitments. In addition, our customers can cancel purchase orders or defer the shipments of our products under certain circumstances. Our products are manufactured using a silicon foundry according to our estimates of customer demand, which requires us to make separate demand forecast assumptions for every customer, each of which may introduce significant variability into our aggregate estimate. We have limited visibility into future customer demand and the product mix that our customers will require, which could adversely affect our revenue forecasts and operating margins. Moreover, because our target markets are relatively new, many of our customers have difficulty accurately forecasting their product requirements and estimating the timing of their new product introductions, which ultimately affects their demand for our products. In addition, the rapid pace of innovation in our industry could render significant portions of our inventory obsolete. Excess or obsolete inventory levels could result in unexpected expenses or increases in our reserves that could adversely affect our business, operating results and financial condition. Conversely, if we were to underestimate customer demand or if sufficient manufacturing capacity were unavailable, we could forego revenue opportunities, potentially lose market share and damage our customer relationships. In addition, any significant future cancellations or deferrals of product orders or the return of previously sold products due to manufacturing defects could materially and adversely impact our profit margins, increase our write-offs due to product obsolescence and restrict our ability to fund our operations.

Winning business is subject to lengthy competitive selection processes that require us to incur significant expenditures. Even if we begin a product design, a customer may decide to cancel or change its product plans, which could cause us to generate no revenue from a product and adversely affect our results of operations.

The selection process for obtaining new business typically is lengthy and can require us to incur significant design and development expenditures and dedicate scarce engineering resources in pursuit of a single customer opportunity. We may not win the competitive selection process and may never generate any revenue despite incurring significant design and development expenditures. These risks are exacerbated by the fact that some of our customers’ products likely will have short life cycles. Failure to obtain business in a new product design could prevent us from offering an entire generation of a product, even though this has not occurred to date. This could cause us to lose revenue and require us to write off obsolete inventory, and could weaken our position in future competitive selection processes.

After securing new business, we may experience delays in generating revenue from our products as a result of the lengthy development cycle typically required. Our customers generally take a considerable amount of time to evaluate our products. The typical time from early engagement by our sales force to actual product introduction could run from 12 to 24 months. The delays inherent in these lengthy sales cycles increase the risk that a customer will decide to cancel, curtail, reduce or delay its product plans, causing us to lose anticipated sales. In addition, any delay or cancellation of a customer’s plans could materially and adversely affect our financial results, as we may have incurred significant expense and generated no revenue. Finally, our customers’ failure to successfully market and sell their products could reduce demand for our products and materially and adversely affect our business, financial condition and results of operations. If we were unable to generate revenue after incurring substantial expenses to develop any of our products, our business would suffer.

Many of our products will have long sales cycles, which may cause us to expend resources without an acceptable financial return and which makes it difficult to plan our expenses and forecast our revenue.

Many of our products will have long sales cycles that involve numerous steps, including initial customer contacts, specification writing, engineering design, prototype fabrication, pilot testing, regulatory approvals (if needed), sales and marketing and commercial manufacture. During this time, we may expend substantial financial resources and management time and effort without any assurance that product sales will result. The anticipated long sales cycle for some of our products makes it difficult to predict the quarter in which sales may occur. Delays in sales may cause us to expend resources without an acceptable financial return and make it difficult to plan expenses and forecast revenues.

We are subject to the cyclical nature of the semiconductor industry.

The semiconductor industry is highly cyclical and is characterized by constant and rapid technological change, rapid product obsolescence and price erosion, evolving standards, short product life cycles and wide fluctuations in product supply and demand. The industry is experiencing a significant downturn during the current global recession. These downturns have been characterized by diminished product demand, production overcapacity, high inventory levels and accelerated erosion of average selling prices. The current downturn and any future downturns could have a material adverse effect on our business and operating results. Furthermore, any upturn in the semiconductor industry could result in increased competition for access to third-party foundry and assembly capacity. We are dependent on the availability of this capacity to manufacture and assemble our products, and our third-party manufacturers have not provided assurances that adequate capacity will be available to us in the future.

A large proportion of our products are directed at the telecommunications and networking markets, which continue to be subject to overcapacity.

The technology equipment industry is cyclical and has experienced significant and extended downturns in the past, often in connection with, or in anticipation of, maturing product cycles, and capital spending cycles and declines in general economic conditions. The cyclical nature of these markets has led to significant imbalances in demand, inventory levels and production capacity. It has also accelerated the decrease of average selling prices per unit. We may experience periodic fluctuations in our financial results because of these or other industry-wide conditions. Developments that adversely affect the telecommunications or networking markets, including delays in traffic growth and changes in U.S. government regulation, could halt our efforts to generate revenue or cause revenue growth to be slower than anticipated from sales of electro-optic modulators, semiconductors and related products. Reduced spending and technology investment by telecommunications companies may make it more difficult for our products to gain market acceptance. Our potential customers may be less willing to purchase new technology such as our technology or invest in new technology development when they have reduced capital expenditure budgets.

We derive a significant portion of our revenue from a small number of customers and the loss of one or more of these key customers, the diminished demand for our products from a key customer, or the failure to obtain certifications from a key customer or its distribution channel could significantly reduce our revenue and profits.

A relatively small number of customers account for a significant portion of our revenue in any particular period. For instance, Alcatel and contracts with the U.S. government accounted for 13% and 12%, respectively, of revenue for the first nine months of fiscal year 2010 and 23% and 24%, respectively, of revenue for fiscal year 2009. One or more of our key customers may discontinue operations as a result of consolidation, liquidation or otherwise, or reduce significantly its business with us due to the current economic conditions. Reductions, delays and cancellation of orders from our key customers or the loss of one or more key customers could significantly further reduce our revenue and profits. There is no assurance that our current customers will continue to place orders with us, that orders by existing customers will continue at current or historical levels or that we will be able to obtain orders from new customers.

We rely on a small number of development contracts with the U.S. Department of Defense and government contractors for a large portion of our revenue. The termination or non-renewal of one or more of these contracts could reduce our future revenue.

Twelve percent and twenty-four percent of our revenue for the nine months ended October 3, 2010 and year ended December 31, 2009 was derived from performance on a limited number of development contracts with various agencies within the U.S. government. Any failure by us to continue these relationships or significant disruption or deterioration of our relationship with the U.S. Department of Defense may reduce revenues. Government programs must compete with programs managed by other contractors for limited and uncertain levels of funding. The total amount and levels of funding are susceptible to significant fluctuations on a year-to-year basis. Our competitors frequently engage in efforts to expand their business relationships with the government and are likely to continue these efforts in the future. In addition, our development contracts with government agencies are subject to potential profit and cost limitations and standard provisions that allow the U.S. government to terminate such contracts at any time at its convenience. Termination of these development contracts, a shift in government spending to other programs in which we are not involved, or a reduction in government spending generally or defense spending specifically could severely harm our business. We intend to continue to compete for government

contracts and expect such contracts will be a large percentage of our revenue for the foreseeable future. The development contracts in place with various agencies within the U.S. Department of Defense require ongoing compliance with applicable federal procurement regulations. Violations of these regulations can result in civil, criminal or administrative proceedings involving fines, compensatory and punitive damages, restitution and forfeitures, as well as suspensions or prohibitions from entering into such development contracts. Also, the reporting and appropriateness of costs and expenses under these development contracts are subject to extensive regulation and audit by the Defense Contract Audit Agency (DCAA), an agency of the U.S. Department of Defense. In addition, we obtain provisional billing rates from the DCAA to bill under government contracts. Any differences between provisional billing rates and actual billed rates may result in an adjustment to revenue. In the fourth quarter of fiscal 2009, we reduced revenue by $1.3 million as a result of such an adjustment applied to government contract revenue for all of fiscal 2009. Any failure to comply with applicable government regulations could jeopardize our development contracts and otherwise harm our business.

Our future success depends in part on the continued service of our key senior management, design engineering, sales, marketing, and technical personnel and our ability to identify, hire and retain additional, qualified personnel.

Our future success depends to a significant extent upon the continued service of our senior management personnel, including our Chief Executive Officer, Dr. Avi Katz and our Chief Technical Officer, Andrea Betti-Berutto. We do not maintain key person life insurance on any of our executive officers and do not intend to purchase any in the future. The loss of key senior executives could have a material adverse effect on our business. There is intense competition for qualified personnel in the semiconductor and polymer industries, and we may not be able to continue to attract and retain engineers or other qualified personnel necessary for the development of our business, or to replace engineers or other qualified personnel who may leave our employment in the future. There may be significant costs associated with recruiting, hiring and retaining personnel. Periods of contraction in our business may inhibit our ability to attract and retain our personnel. Loss of the services of, or failure to recruit, key design engineers or other technical and management personnel could be significantly detrimental to our product development or other aspects of our business.

We will be subject to the risks frequently experienced by early stage companies.

The likelihood of our success must be considered in light of the risks frequently encountered by early stage companies, especially those formed to develop and market new technologies. These risks include our potential inability to:

•

establish product sales and marketing capabilities;

•

establish and maintain markets for our potential products;

•

identify, attract, retain and motivate qualified personnel;

•

continue to develop and upgrade our technologies to keep pace with changes in technology and the growth of markets using semiconductors and polymer materials;

•

develop expanded product production facilities and outside contractor relationships;

•

maintain our reputation and build trust with customers;

•

improve existing and implement new transaction processing, operational and financial systems;

•

scale up from small pilot or prototype quantities to large quantities of product on a consistent basis;

•

contract for or develop the internal skills needed to master large volume production of our products; and

•

fund the capital expenditures required to develop volume production due to the limits of available financial resources.

Our future growth will suffer if we do not achieve sufficient market acceptance of our products.

Our success depends, in part, upon our ability to maintain and gain market acceptance of our products. To be accepted, these products must meet the quality, technical performance and price requirements of our customers and potential customers. The optical communications industry is currently fragmented with many competitors developing different technologies. Some of these technologies may not gain market acceptance. Our products, including products based on polymer materials, may not be accepted by OEMs and systems integrators of optical

communications networks and consumer electronics. In addition, even if we achieve some degree of market acceptance for our potential products in one industry, we may not achieve market acceptance in other industries for which we are developing products, and which are critical to meeting our financial targets.

Many of our current products, particularly those based on polymer technology, are either in the development stage or are being tested by potential customers. We cannot be assured that our development efforts or customer tests will be successful or that they will result in actual material sales, or that such products will be commercially viable.

Achieving market acceptance for our products will require marketing efforts and the expenditure of financial and other resources to create product awareness and demand by customers. It will also require the ability to provide excellent customer service. We may be unable to offer products that compete effectively due to our limited resources and operating history. Also, certain large corporations may be predisposed against doing business with a company of our limited size and operating history. Failure to achieve broad acceptance of our products by customers and to compete effectively would harm our operating results.

Successful commercialization of current and future products will require us to maintain a high level of technical expertise.

Technology in our target markets is undergoing rapid change. To succeed in these target markets, we will have to establish and maintain a leadership position in the technology supporting those markets. Accordingly, our success will depend on our ability to:

•

accurately predict the needs of target customers and develop, in a timely manner, the technology required to support those needs;

•

provide products that are not only technologically sophisticated but are also available at a price acceptable to customers and competitive with comparable products;

•

establish and effectively defend our intellectual property; and

•

enter into relationships with other companies that have developed complementary technology into which our products may be integrated.

We cannot assure you that we will be able to achieve any of these objectives.

The failure to compete successfully could harm our business.

We face competitive pressures from a variety of companies in our target markets. The telecom, data-com and consumer opto-electronics markets are highly competitive and we expect that domestic and international competition will increase in these markets, due in part to deregulation, rapid technological advances, price erosion, changing customer preferences and evolving industry standards. Increased competition could result in significant price competition, reduced revenues or lower profit margins. Many of our competitors and potential competitors have or may have substantially greater research and product development capabilities, financial, scientific, marketing, and manufacturing and human resources, name recognition and experience than we do. As a result, these competitors may:

•

succeed in developing products that are equal to or superior to our products or that will achieve greater market acceptance than our products;

•

devote greater resources to developing, marketing or selling their products;

•

respond more quickly to new or emerging technologies or scientific advances and changes in customer requirements, which could render our technologies or potential products obsolete;

•

introduce products that make the continued development of our potential products uneconomical;

•

obtain patents that block or otherwise inhibit our ability to develop and commercialize potential products;

•

withstand price competition more successfully than us;

•

establish cooperative relationships among themselves or with third parties that enhance their ability to address the needs of prospective customers better than us; and

•

take advantage of acquisitions or other opportunities more readily than us.

Competitors may offer enhancements to existing products, or offer new products based on new technologies, industry standards or customer requirements that are available to customers on a more timely basis than comparable products from our company or that have the potential to replace or provide lower cost alternatives to our products. The introduction of enhancements or new products by competitors could render our existing and future products obsolete or unmarketable. Each of these factors could have a material adverse effect on our company’s business, financial condition and results of operations.

We may be unable to obtain effective intellectual property protection for our potential products and technology.

Any intellectual property that we have or may acquire, license or develop in the future may not provide meaningful competitive advantages. Our patents and patent applications, including those we license, may be challenged by competitors, and the rights granted under such patents or patent applications may not provide meaningful proprietary protection. For example, there are patents held by third parties that relate to polymer materials and electro-optic devices. These patents could be used as a basis to challenge the validity or limit the scope of our patents or patent applications. A successful challenge to the validity or limitation of the scope of our patents or patent applications could limit our ability to commercialize the technology and, consequently, reduce revenues.

Moreover, competitors may infringe our patents or those that we license, or successfully avoid these patents through design innovation. To combat infringement or unauthorized use, we may need to resort to litigation, which can be expensive and time-consuming and may not succeed in protecting our proprietary rights. In addition, in an infringement proceeding, a court may decide that our patents or other intellectual property rights are not valid or are unenforceable, or may refuse to stop the other party from using the intellectual property at issue on the ground that it is non-infringing. Policing unauthorized use of our intellectual property is difficult and expensive, and we may not be able to, or have the resources to, prevent misappropriation of our proprietary rights, particularly in countries where the laws may not protect these rights as fully as the laws of the United States.

We also rely on the law of trade secrets to protect unpatented technology and know-how. We try to protect this technology and know-how by limiting access to those employees, contractors and strategic partners with a need to know this information and by entering into confidentiality agreements with these parties. Any of these parties could breach the agreements and disclose our trade secrets or confidential information to competitors, or such competitors might learn of the information in other ways. Disclosure of any trade secret not protected by a patent could materially harm our business.

We may be subject to patent infringement claims, which could result in substantial costs and liability and prevent us from commercializing potential products.

Third parties may claim that our potential products or related technologies infringe their patents. Any patent infringement claims brought against us may cause us to incur significant expenses, divert the attention of management and key personnel from other business concerns and, if successfully asserted, require us to pay substantial damages. In addition, as a result of a patent infringement suit, we may be forced to stop or delay developing, manufacturing or selling potential products that are claimed to infringe a patent covering a third party’s intellectual property unless that party grants us rights to use its intellectual property. We may be unable to obtain these rights on acceptable terms, if at all. Even if we are able to obtain rights to a third party’s patented intellectual property, these rights may be non-exclusive, and therefore competitors may obtain access to the same intellectual property. Ultimately, we may be unable to commercialize our potential products or may have to cease some business operations as a result of patent infringement claims, which could severely harm our business.

If our potential products infringe the intellectual property rights of others, we may be required to indemnify customers for any damages they suffer. Third parties may assert infringement claims against our current or potential customers. These claims may require us to initiate or defend protracted and costly litigation on behalf of customers, regardless of the merits of these claims. If any of these claims succeed, we may be forced to pay damages on behalf of these customers or may be required to obtain licenses for the products they use. If we cannot obtain all necessary licenses on commercially reasonable terms, we may be unable to continue selling such products.

The technology that we license from various third parties may be subject to government rights and retained rights of the originating research institution.

We license technology from various companies or research institutions, such as the University of Washington. Many of these partners and licensors have obligations to government agencies or universities. Under their agreements, a government agency or university may obtain certain rights over the technology that we have developed and licensed, including the right to require that a compulsory license be granted to one or more third parties selected by the government agency.

In addition, our partners often retain certain rights under their licensing agreements, including the right to use the technology for noncommercial academic and research use, to publish general scientific findings from research related to the technology, and to make customary scientific and scholarly disclosures of information relating to the technology. It is difficult to monitor whether such partners limit their use of the technology to these uses, and we could incur substantial expenses to enforce our rights to this licensed technology in the event of misuse.

If we fail to develop and maintain the quality of our manufacturing processes, our operating results would be harmed.

The manufacture of our products is a multi-stage process that requires the use of high-quality materials and advanced manufacturing technologies. With respect to our polymer-based products, polymer-related device development and manufacturing must occur in a highly controlled, clean environment to minimize particles and other yield- and quality-limiting contaminants. In spite of stringent quality controls, weaknesses in process control or minute impurities in materials may cause a substantial percentage of a product in a lot to be defective. If we are unable to develop and continue to improve on our manufacturing processes or to maintain stringent quality controls, or if contamination problems arise, our operating results would be harmed.

The complexity of our products may lead to errors, defects and bugs, which could result in the necessity to redesign products and could negatively impact our reputation with customers.

Products as complex as ours may contain errors, defects and bugs when first introduced or as new versions are released. Delivery of products with production defects or reliability, quality or compatibility problems could significantly delay or hinder market acceptance of our products or result in a costly recall and could damage our reputation and adversely affect our ability to retain existing customers and to attract new customers. In particular, certain products are customized or designed for integration into specific network systems. If our products experience defects, we may need to undertake a redesign of the product, a process which may result in significant additional expenses.

We may also be required to make significant expenditures of capital and resources to resolve such problems. There is no assurance that problems will not be found in new products after commencement of commercial production, despite testing by us, our suppliers and our customers.

We could be exposed to significant product liability claims that could be time-consuming and costly and impair our ability to obtain and maintain insurance coverage.

We may be subject to product liability claims if any of our products are alleged to be defective or harmful. Product liability claims or other claims related to our potential products, regardless of their outcome, could require us to spend significant time and money in litigation, divert management’s time and attention from other business concerns, require us to pay significant damages, harm our reputation or hinder acceptance of our products. Any successful product liability claim may prevent us from obtaining adequate product liability insurance in the future on commercially reasonable terms. Any inability to obtain sufficient insurance coverage at an acceptable cost or otherwise to protect against potential product liability claims could impair our ability to commercialize our products. In addition, certain of our products are sold under warranties. The failure of our products to meet the standards set forth in such warranties could result in significant expenses to us.

If we fail to effectively manage our growth, and effectively transition from our focus on research and development activities to commercially successful products, our business could suffer.

Failure to manage growth of operations could harm our business. To date, a large number of our activities and resources have been directed at the research and development of our technologies and development of potential

related products. The transition from a focus on research and development to being a vendor of products requires effective planning and management. Additionally, growth arising from the expected synergies from the acquisition of ChipX will require effective planning and management. Future expansion will be expensive and will likely strain management and other resources.

In order to effectively manage growth, we must:

•

continue to develop an effective planning and management process to implement our business strategy;

•

hire, train and integrate new personnel in all areas of our business; and

•

expand our facilities and increase capital investments.

There is no assurance that we will be able to accomplish these tasks effectively or otherwise effectively manage our growth.

Our business, financial condition and operating results would be harmed if we do not achieve anticipated revenues.

From time to time, in response to anticipated long lead times to obtain inventory and materials from outside contract manufacturers, suppliers and foundries, we may need to order materials in advance of anticipated customer demand. This advance ordering may result in excess inventory levels or unanticipated inventory write-downs if expected orders fail to materialize, or other factors render our products less marketable. If we are forced to hold excess inventory or incur unanticipated inventory write-downs, our financial condition and operating results could be materially harmed.

Our expense levels are relatively fixed and are based on our expectations of future revenue. We will have limited ability to reduce expenses quickly in response to any revenue shortfalls. Changes to production volumes and impact of overhead absorption may result in a decline in our financial condition or liquidity.

We could suffer unrecoverable losses on our customers’ accounts receivable which would adversely affect our financial results.

Our operating cash flows are dependent on the continued collection of receivables. We could suffer losses if a customer is unable to pay. A significant loss on any accounts receivable would have an adverse impact on our business and financial results.

The industry and markets in which we compete are subject to consolidation, which may result in stronger competitors, fewer customers and reduced demand.

There has been industry consolidation among communications IC companies, network equipment companies and telecommunications companies in the past. This consolidation is expected to continue as companies attempt to strengthen or hold their positions in evolving markets. Consolidation may result in stronger competitors, fewer customers and reduced demand, which in turn could have a material adverse effect on our business, operating results, and financial condition.

Our operating results are subject to fluctuations because we have international sales.

International sales account for a large portion of our revenue and may account for an increasing portion of future revenue. The revenue derived from international sales may be subject to certain risks, including:

•

foreign currency exchange fluctuations;

•

changes in regulatory requirements;

•

tariffs and other barriers;

•

timing and availability of export licenses;

•

political and economic instability;

•

difficulties in accounts receivable collections;

•

difficulties in staffing and managing foreign operations;

•

difficulties in managing distributors;

•

difficulties in obtaining governmental approvals for communications and other products;

•

reduced or uncertain protection for intellectual property rights in some countries;

•

longer payment cycles to collect accounts receivable in some countries;

•

the burden of complying with a wide variety of complex foreign laws and treaties; and

•

potentially adverse tax consequences.

We are subject to regulatory compliance related to our operations.

We are subject to various U.S. governmental regulations related to occupational safety and health, labor and business practices. Failure to comply with current or future regulations could result in the imposition of substantial fines, suspension of production, alterations of our production processes, cessation of operations, or other actions, which could harm our business.

We may incur liability arising from our use of hazardous materials.

Our business and facilities are subject to a number of federal, state and local laws and regulations relating to the generation, handling, treatment, storage and disposal of certain toxic or hazardous materials and waste products that are used or generated in our operations. Many of these environmental laws and regulations subject current or previous owners or occupiers of land to liability for the costs of investigation, removal or remediation of hazardous materials. In addition, these laws and regulations typically impose liability regardless of whether the owner or occupier knew of, or was responsible for, the presence of any hazardous materials and regardless of whether the actions that led to their presence were taken in compliance with the law. Our domestic facilities use various chemicals in manufacturing processes which may be toxic and covered by various environmental controls. These hazardous materials may be stored on site. The waste created by use of these materials is transported off-site by an unaffiliated waste hauler. Many environmental laws and regulations require generators of waste to take remedial actions at an off-site disposal location even if the disposal was conducted lawfully. The requirements of these laws and regulations are complex, change frequently and could become more stringent in the future. Failure to comply with current or future environmental laws and regulations could result in the imposition of substantial fines, suspension of production, alteration of production processes, cessation of operations or other actions, which could severely harm our business.

We may be unable to export some of our potential products or technology to other countries, convey information about our technology to citizens of other countries or sell certain products commercially, if the products or technology are subject to U.S. export or other regulations.

We are developing certain products that we believe the U.S. government and other governments may be interested in using for military and information gathering or antiterrorism activities. U.S. government export regulations may restrict us from selling or exporting these potential products into other countries, exporting our technology to those countries, conveying information about our technology to citizens of other countries or selling these potential products to commercial customers. We may be unable to obtain export licenses for products or technology if necessary. We currently cannot assess whether national security concerns would affect our potential products and, if so, what procedures and policies we would have to adopt to comply with applicable existing or future regulations.

We are subject to risks associated with the imposition of legislation and regulations relating to the import or export of high technology products. We cannot predict whether quotas, duties, taxes or other charges or restrictions upon the importation or exportation of our products will be implemented by the United States or other countries.

Various laws and regulations potentially affect the import and export of our products, including export control, tax and customs laws. Furthermore, some customer purchase orders and agreements are governed by foreign laws, which may differ significantly from laws in the United States. As a result, our ability to enforce our rights under such agreements may be limited compared with our ability to enforce our rights under agreements governed by laws in the United States.

Our business is subject to foreign currency risk.

Sales to customers located outside of the United States comprised 75%, 51% and 49% of our revenue for 2008, 2009 and the first nine months of 2010, respectively. In addition, we have a subsidiary overseas (Switzerland) which records its operating expenses in a foreign currency. Because sales of our products have been denominated to date primarily in U.S. dollars, increases in the value of the U.S. dollar could increase the price of our products so that they become relatively more expensive to customers in the local currency of a particular country, leading to a reduction in sales and profitability in that country. Future international activity may result in increased foreign currency denominated sales. Gains and losses on the conversion to U.S. dollars of accounts receivable, accounts payable and other monetary assets and liabilities arising from international operations may contribute to fluctuations in our results of operations. We currently do not have hedging or other programs in place to protect against adverse changes in the value of the U.S. dollar as compared to other currencies to minimize potential adverse effects.

Restrictive covenants under our credit facility with Silicon Valley Bank may adversely affect our operations.

Our loan and security agreement with Silicon Valley Bank contains a number of restrictive covenants that will impose significant operating and financial restrictions on our ability to, without prior written approval from Silicon Valley Bank:

•

Merge or consolidate, or permit any of our subsidiaries to merge or consolidate, with or into any other business organization, or acquire, or permit any of our subsidiaries to acquire, all or substantially all of the capital stock or property of another person;

•

Create, incur, or assume any indebtedness, other than certain indebtedness permitted under the loan and security agreement with Silicon Valley Bank; and

•

Pay any dividends or make any distributions or payment on, or redeem, retire or repurchase any capital stock.

A failure to comply with the covenants contained in our loan and security agreement could result in an event of default under the agreement which, if not cured or waived, could result in the acceleration of the indebtedness and have a material adverse affect on our business, financial condition and results of operations.

We have previously identified a material weakness in our internal control over financial reporting. If we fail to remedy our material weakness or otherwise fail to maintain effective internal control over financial reporting, the accuracy and timing of our financial reporting may be adversely affected.

In connection with the preparation of our consolidated financial statements for the years ended December 31, 2009 and 2008, material weaknesses in our internal controls over financial reporting, as defined in rules established by the Public Company Accounting Oversight Board, were identified. A “material weakness” is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the annual or interim financial statements would not be prevented or detected on a timely basis. The material weakness was attributed to us not maintaining a sufficient complement of personnel with an appropriate level of accounting knowledge, experience and training in the application of generally accepted accounting principles commensurate with our financial reporting requirements. We have adopted a remediation plan which we are in the process of implementing, including through the hiring in February 2010 of a corporate controller with technical accounting and financial reporting experience, and we expect to remediate the material weaknesses during 2010.

In addition, other material weaknesses or significant deficiencies in our internal control over financial reporting may be identified in the future. If we fail to remediate the material weakness or fail to implement required new or improved controls, or encounter difficulties in their implementation, it could harm our operating results, cause failure to meet our SEC reporting obligations on a timely basis or result in material misstatements in our annual or interim financial statements.

Risks Related to Ownership of Our Common Stock

There may be a limited public market for our common shares, and the ability of our stockholders to dispose of their common shares may be limited.

Our common shares have been traded on the OTC Bulletin Board since December 2008. We cannot foresee the degree of liquidity that will be associated with our common shares. A holder of our common shares may not be able to liquidate his, her or its investment in a short time period or at the market prices that currently exist at the time the holder decides to sell. The market price for our common stock may fluctuate in the future, and such volatility may bear no relation to our performance.

Broker-dealers often decline to trade in OTC stocks given that the market for such securities is often limited, the stocks are more volatile, and the risk to investors is greater than with stocks listed on other national securities exchanges. Consequently, selling our common stock can be difficult because smaller quantities of shares can be bought and sold, transactions can be delayed and news media coverage of our Company may be reduced. These factors could result in lower prices and larger spreads in the bid and ask prices for shares of our common stock as well as lower trading volume. Investors should realize that they may be unable to sell shares of our common stock that they purchase. Accordingly, investors must be able to bear the financial risks associated with losing their entire investment in our common stock.

Our common stock may be subject to penny stock rules, which may make it more difficult for our stockholders to sell their common stock.

Our common stock may be considered a “penny stock” pursuant to Rule 3a51-1 of the Exchange Act. Broker-dealer practices in connection with transactions in penny stocks are regulated by certain penny stock rules adopted by the SEC. Penny stocks generally are defined as equity securities with a price of less than $5.00 per share. The penny stock rules require a broker-dealer, prior to purchase or sale of a penny stock not otherwise exempt from the rules, to deliver to the customer a standardized risk disclosure document that provides information about penny stocks and the risks associated with the penny stock market. The broker-dealer also must provide the customer with current bid and offer quotations for the penny stock, the compensation of the broker-dealer and its salesperson in the transaction, and monthly account statements showing the market value of each penny stock held in the customer account. In addition, the penny stock rules generally require that, prior to a transaction in a penny stock, the broker-dealer make a special written determination that the penny stock is a suitable investment for the purchaser and receive the purchaser’s written agreement to the transaction. These disclosure requirements may have the effect of reducing the level of trading activity in the secondary market of a stock that becomes subject to the penny stock rules.

Substantial future sales of our common stock in the public market could cause our stock price to fall.

As of October 3, 2010, we had approximately 12,195,031 shares of common stock outstanding, approximately 1,680,481 shares of common stock available for future issuance under our stock option plans and warrants to purchase approximately 2,182,038 shares outstanding. Additional sales of our common stock in the public market after the effectiveness of registration statements we have filed with the SEC or the perception that such sales could occur, could cause the market price of our common stock to decline. We may issue additional shares of our common stock in the future in private placements, public offerings or to finance mergers or acquisitions.

Our quarter-to-quarter performance may vary substantially, and this variance, as well as general market conditions, may cause our stock price to fluctuate greatly and potentially expose us to litigation.

The revenues for our product lines and our quarterly operating results may vary significantly based on many factors, including:

•

reductions or delays in funding of development programs involving new polymer materials technologies by the U.S. government;

•

additions of new customers;

•

fluctuating demand for our products and technologies;

•

announcements or implementation by competitors of technological innovations or new products;

•

the status of particular development programs and the timing of performance under specific development agreements;

•

timing and amounts relating to the expansion of operations;

•

costs related to possible future acquisitions of technologies or businesses;

•

communications, information technology and semiconductor industry conditions;

•

fluctuations in the timing and amount of customer requests for product shipments;

•

the reduction, rescheduling or cancellation of orders by customers, including as a result of slowing demand for our products or our customers’ products;

•

changes in the mix of products that our customers buy;

•

competitive pressures on selling prices;

•

the ability of our customers to obtain components from their other suppliers;

•

fluctuations in manufacturing output, yields or other problems or delays in the fabrication, assembly, testing or delivery of our products or our customers’ products; and

•

increases in the costs of products or discontinuance of products by suppliers.

We base our current and future expense estimates, in large part, on estimates of future revenue, which are difficult to predict. We expect to continue to make significant operating and capital expenditures in the area of research and development and to invest in and expand production, sales, marketing and administrative systems and processes. We may be unable to, or may elect not to, adjust spending quickly enough to offset any unexpected revenue shortfall. If our increased expenses are not accompanied by increased revenue in the same quarter, our quarterly operating results would be harmed.

In future quarters, our results of operations may fall below the expectations of investors and the trading price of our common stock may decline as a consequence. We believe that quarter-to-quarter comparisons of our operating results will not be a good indication of future performance and should not be relied upon to predict the future performance of our stock price. In the past, companies that have experienced volatility in the market price of their stock have often been subject to securities class action litigation. We may be the target of this type of litigation in the future. Securities litigation could result in substantial costs and divert our attention from other business concerns, which could seriously harm our business.

Provisions in our amended and restated certificate of incorporation and amended and restated bylaws may prevent takeover attempts that could be beneficial to our stockholders.

Provisions of our certificate of incorporation and bylaws could discourage a takeover of our company even if a change of control would be beneficial to the interests of our stockholders. These charter provisions include the following:

•

a requirement that our board of directors be divided into three classes, with approximately one-third of the directors to be elected each year; and

•

supermajority voting requirements (two-thirds of outstanding shares) applicable to the approval of any merger or other change of control transaction that is not approved by our continuing directors. The continuing directors are all of the directors as of the effective time of a merger or who are elected to the board upon the recommendation of a majority of the continuing directors.

We have never paid dividends on our capital stock, and we do not anticipate paying cash dividends for the foreseeable future.

We have never declared or paid cash dividends on our capital stock. We do not anticipate paying any cash dividends on our common stock for the foreseeable future. We currently intend to retain all available funds and future earnings, if any, to fund the development and growth of our business. As a result, capital appreciation, if any, of our common stock will be our stockholders’ sole source of potential gain for the foreseeable future.

ITEM 6.

EXHIBITS

(a) Exhibits


Exhibit Number		Description

31.1		Chief Executive Officer certification pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2		Chief Financial Officer certification pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1		Chief Executive Officer certification pursuant to Rule 13a-14(b) or Rule 13d-14(b) and Section 1350, Chapter 63 of Title 18 United States Code (18 U.S.C. 1350) as adopted pursuant to Section 906 of Sarbanes-Oxley Act of 2002.

32.2		Chief Financial Officer certification pursuant to Rule 13a-14(b) or Rule 15d-14(b) and Section 1350, Chapter 63 of Title 18 United States Code (18 U.S.C. 1350) as adopted pursuant to Section 906 of Sarbanes-Oxley Act of 2002.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

GIGOPTIX, INC.


Date: November 17, 2010				/s/ AVI S. KATZ
				Dr. Avi S. Katz Chief Executive Officer and Chairman of the Board

Date: November 17, 2010				/s/ RONALD K. SHELTON
				Ronald K. Shelton Chief Financial Officer

Large accelerated filer

Accelerated filer

Non-accelerated filer

¨ (Do not check if a smaller reporting company)

Smaller reporting Company